Apparatus and method of placement of a graft or graft system

Description

BACKGROUND OF THE DISCLOSURE

Technical Field

Endoluminal vascular prostheses delivery devices and methods of deploying such prostheses for use in the treatment of aneurysms at branches of arterial vessels, in particular the aorta, are described.

Description of the Related Art

An abdominal aortic aneurysm is a sac caused by an abnormal dilation of the wall of the aorta, a major artery of the body, as it passes through the abdomen.

In certain conditions, the diseased region of the blood vessels can extend across branch vessels. The blood flow into these branch vessels is critical for the perfusion of the peripheral regions of the body and vital organs. Many arteries branch off the aorta. For example, the carotid arteries supply blood into the brain, the renal arteries supply blood into the kidneys, the superior mesenteric artery (“SMA”) supplies the pancreas, the hypogastric arteries supply blood to the reproductive organs, and the subclavian arteries supply blood to the arms. When the aorta is diseased, the branch vessels may also be affected. Thoracic aortic aneurysms may involve the subclavian and carotid arteries, abdominal aneurysms may involve the SMA, renal and hypogastric arteries. Aortic dissections may involve all branch vessels mentioned above. When this occurs, it may be detrimental to implant a conventional tubular graft or stent graft in this location of the aorta or the blood vessel, since such a graft may obstruct the flow of blood from the aorta into the branches.

Prior branch graft arrangements are complex and require many steps of insertion and removal to orient and align fenestrations in a main body to the surrounding anatomy and still more steps to insert, deploy, and seal a branch graft (covered stent) to the main stent graft body and to the wall of the branch vessel without unacceptable leakage.

Thus, there is a need to simplify the delivery of branch graft devices to provide improved reliability and reduced procedure duration.

SUMMARY OF SOME EXEMPLIFYING EMBODIMENTS

Designs and methods of placement of a branch graft or branch graft system having lateral openings in the main graft are disclosed. The main graft is positioned within the main blood vessel such as the aorta so that the lateral openings (also referred to herein as fenestrations) can be aligned with the branch blood vessels, to allow blood to flow through the openings in the main graft and into the branch vessels. The positions of the branch blood vessels can vary from one patient's anatomy to the next, the graft systems disclosed herein allow a surgeon to adjust the position of the fenestrations in the main body so as to align them with the branch vessels to improve the efficiency of branch graft deployment.

The branch graft system can comprise a tubular expandable main body and at least one fenestration or at least one branch graft at any desired location. The main graft body and/or the branch graft can be made from an expandable material, such as but not limited to ePTFE. The main graft can have two fenestrations or branch grafts formed therein at generally diametrically opposed locations or at positions that are offset from the diametrically opposed positions. Depending on the particular patient's anatomy, other cutouts, scallops, or fenestrations, such as but not limited to a fenestration for the superior mesenteric artery (“SMA”), can be formed in the main graft depending on the patient's anatomy and position of the graft.

The main graft body can have a tubular shape and can have a diameter that can be significantly larger than the diameter of the target vessel into which the graft is intended to be deployed. As will be described in greater detail below, the oversized diameter of a portion of the main graft can provide excess or slack graft material in the main graft to allow the fenestrations to each be moved in one or a combination of lateral, axial and angular directions so that the fenestrations can be aligned with the branch arteries.

One or more branch grafts can be supported by the main graft body adjacent to the one or more fenestrations (openings) that can be formed in the main graft body. A compressed branch graft is small enough to allow it to be manipulated into the desired vascular position by moving the branch graft over a guidewire. The branch graft can be expanded to the diameter of the branch vessel by mechanical means, which can be a dilation balloon, or by the removal of a surrounding restraint in the case of a self-expanding device.

Some embodiments relate to a fenestrated graft deployment system, comprising a delivery catheter having a catheter body, a prosthesis having a main graft body, the main graft body having lumen therethrough and a first opening laterally through a wall of the main graft body, a first guidewire prepositioned within the delivery catheter extending through at least a portion of the catheter body into a main lumen of the endoluminal prosthesis and through the first opening in the wall of the prosthesis when the delivery catheter is in a predeployment state. The system can have a first fenestration alignment device extending through at least a portion of the delivery catheter configured to be axially moveable relative to the first guidewire. The first fenestration alignment device can be configured such that a portion of the fenestration alignment device contacts the main graft body adjacent to the first opening to approximately align the first fenestration with an ostium of a target branch vessel when advanced relative to the fenestration.

Some embodiments relate to a fenestration push device for use in a fenestrated prostheses deployment catheter, comprising a body portion defining a lumen therethrough, the lumen having a first diameter or cross-sectional size or perimeter, and a protrusion supported at or adjacent to a distal end of the body portion, the protrusion projecting away from an outside surface of the body portion and defining a second cross-sectional or perimeter size. The second cross-sectional size of the fenestration push device at the location of the protrusion is greater than the first diameter or size of the body portion. Additionally, the second cross-sectional size of the protrusion is greater than a cross-sectional size of a fenestration formed in a respective fenestrated graft.

Some embodiments relate to method of deploying a fenestrated endoluminal prosthesis in a patient's vasculature, comprising advancing a catheter supporting the endoluminal prosthesis therein through a patient's vasculature to a target vessel location, wherein the prosthesis has a main graft body comprising a first opening through a wall thereof, advancing a first guide sheath through the first opening and into a first branch vessel, and advancing a first fenestration alignment device into contact with the prosthesis adjacent to the first opening through the wall of the prosthesis so as to approximately align the first opening with an ostium of the first branch vessel.

Some embodiments or arrangements are directed to methods for deploying an endoluminal prosthesis, comprising advancing a catheter supporting the endoluminal prosthesis therein through a patient's vasculature to a target vessel location, advancing one or more catheters through one or more fenestrations formed in the main graft body and into one or more branch vessels in the patient's vasculature, at least partially expanding at least the second portion of the main graft body, and substantially aligning the one or more fenestrations formed within the second portion of the main graft body with the one or more branch vessels by moving the one or more fenestrations in a circumferential and/or axial direction toward the ostium of the one or more branch vessels. In any of the embodiments or arrangements disclosed herein, the prosthesis can have a main graft body comprising a first portion, a second portion, and a third portion. The second portion of the main graft body has a cross-sectional size that is significantly larger than a cross-sectional size of the first portion and the third portion, and also significantly larger than a cross-sectional size of the target vessel.

Some embodiments or arrangements are directed to methods for deploying a fenestrated prosthesis in a patient's blood vessel having at least a first branch blood vessel, comprising advancing a delivery catheter into a blood vessel, exposing at least one guide sheath, the guide sheath being positioned within the delivery catheter so as to extend from a main lumen of the prosthesis through a first opening formed through a wall of the prosthesis, and advancing an angiographic catheter through the guide sheath and cannulating a first target branch vessel before completely removing the second restraint. The delivery catheter can support the fenestrated prosthesis having a main graft body and at least one fenestration extending through the main graft body, a first restraint restraining a proximal portion of the prosthesis, and a second restraint restraining a distal portion of the prosthesis, the distal portion of the prosthesis being closer to a proximal portion of the delivery catheter than the proximal portion of the prosthesis.

Some embodiments or arrangements are directed to methods for deploying a fenestrated prosthesis in a patient's blood vessel having at least a first branch blood vessel, comprising advancing a delivery catheter into a blood vessel, exposing at least one guide sheath, the guide sheath being positioned within the delivery catheter so as to extend from a main lumen of the prosthesis through a first opening formed through a wall of the prosthesis, and advancing the guide sheath into a first target branch vessel before completely removing the second restraint. The delivery catheter can support the fenestrated prosthesis, and the fenestrated prosthesis can have a main graft body and at least one fenestration therein, a first restraint restraining a proximal portion of the prosthesis, and a second restraint restraining a distal portion of the prosthesis, the distal portion of the prosthesis being closer to a proximal portion of the delivery catheter than the proximal portion of the prosthesis,

Some embodiments or arrangements are directed to delivery systems for deploying an endoluminal prosthesis, comprising a first restraint configured to restrain a portion of the prosthesis, a second restraint configured to restrain a second portion of the prosthesis, a first opening through a wall of the prosthesis, a first guide sheath extending from a proximal end of the delivery system into a main lumen of the endoluminal prosthesis and through the first opening in the wall of the prosthesis, a first stent configured to support the first portion of the endoluminal prosthesis, and a second stent configured to support the second portion of the endoluminal prosthesis, wherein the guide sheath is moveable before removing the first and second restraints. The first opening can be positioned between the first and second portions.

Some embodiments or arrangements are directed to endoluminal prostheses comprising a main graft body defining a flow lumen therethrough, a first opening passing through a wall of the main graft body, and a first support member supported by the main graft body and overlapping an edge of the first opening, the first support member being configured to increase the tear resistance of the main graft body adjacent to the first opening.

Some embodiments or arrangements are directed to methods for forming an endoluminal prosthesis having at least one reinforced fenestration in a main portion thereof, comprising forming a graft body having a tubular main body portion, forming a first opening through a wall of the main body portion, the first opening having a first state in which the first opening is substantially unstretched and a second state in which the first opening is stretched so that a size of the first opening increases, advancing a tubular member partially through the first opening, and fastening a first end portion and a second end portion of the tubular member to the wall of the main body portion adjacent to the first opening so that the tubular member completely overlaps an edge of the first opening.

Some embodiments or arrangements are directed to methods of deploying an endoluminal prosthesis, comprising advancing a catheter supporting the endoluminal prosthesis therein through a patient's vasculature to a target vessel location, advancing one or more catheters through one or more fenestrations formed in the main graft body and into one or more branch vessels in the patient's vasculature, at least partially expanding at least the second portion of the main graft body, and substantially aligning the one or more fenestrations formed within the second portion of the main graft body with the one or more branch vessels by moving the one or more fenestrations in a circumferential and/or axial direction toward an ostium of the one or more branch vessels by advancing one or more alignment devices relative to the one or more fenestrations, engaging such fenestrations with the one or more alignment devices, and aligning such fenestrations with the one or more branch vessels. The prosthesis can have a main graft body which can have a first portion, a second portion, and a third portion, and the second portion of the main graft body can have a cross-sectional size that is significantly larger than a cross-sectional size of the first portion and the third portion, and also significantly larger than a cross-sectional size of the target vessel.

Some embodiments or arrangements are directed to methods of deploying a graft in a patient's blood vessel having at least a first branch blood vessel, comprising advancing a delivery catheter into a blood vessel, the delivery catheter supporting a fenestrated prosthesis comprising a main graft body therein, exposing at least one branch sheath, the branch sheath being positioned within the delivery catheter so as to extend from a main lumen of the prosthesis through a first opening formed through a wall of the main graft body, advancing an angiographic catheter into the branch sheath and cannulating a first target branch vessel before expanding the main graft body of the prosthesis, engaging the main graft body adjacent to the first opening, and advancing the main graft body adjacent to the first opening into approximate alignment with an ostium of the target branch blood vessel.

In any of the embodiments disclosed (directly or by incorporation by reference) herein, main graft body, branch grafts, or any other component of the endoluminal prostheses or deployment systems disclosed herein can have at least one radiopaque suture or marker attached thereto to assist with the placement of such components.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a partial sectional view of a patient's vasculature illustrating an endoluminal prosthesis deployed in the patient's vasculature.

FIG. 2 is a side view of the endoluminal prosthesis illustrated in FIG. 1.

FIG. 3 is a cross-sectional view of the endoluminal prosthesis deployed in the patient's anatomy, taken at 3-3 in FIG. 1, before the fenestrations have been aligned with the respective branch vessels.

FIG. 4 is a cross-sectional view of the endoluminal prosthesis deployed in the patient's anatomy, taken at 3-3 in FIG. 1, after the fenestrations have been aligned with the respective branch vessels.

FIG. 5A is a side view of a catheter system comprising an introducer catheter and a delivery catheter.

FIG. 5B is an oblique view of a catheter system illustrated in FIG. 5A, showing the outer sheath in a partially retracted position.

FIG. 6 is an oblique view of introducer catheter shown in FIGS. 5A and 5B.

FIG. 7 is an exploded view the introducer catheter shown in FIGS. 5A and 5B.

FIG. 8 is a close up view the delivery catheter shown in FIGS. 5A and 5B.

FIG. 9 is an exploded view the delivery catheter shown in FIG. 5A.

FIG. 10 is a sectional view of a portion 10-10 of delivery catheter shown in FIG. 5A.

FIG. 11A is a sectional view of the delivery catheter shown in FIGS. 5A and 5B, taken at 11A-11A in FIG. 10.

FIG. 11B is a sectional view the delivery catheter shown in FIGS. 5A and 5B, taken at 11B-11B in FIG. 10.

FIG. 12 is a side view the catheter system shown in FIG. 5B, showing the outer sheath in a partially retracted position.

FIG. 13 is an close up side view of the portion 13-13 of the catheter system shown in FIG. 12, showing the outer sheath in a partially retracted position.

FIG. 14 is an close up side view of the portion 14-14 of the catheter system shown in FIG. 12, showing the outer sheath in a partially retracted position and the proximal sheath in a partially advanced position.

FIG. 15 is a side view the catheter system shown in FIGS. 5A and 5B, showing the outer sheath in a partially retracted position and one branch sheath and one fenestration alignment component in a partially advanced position.

FIG. 16 is a sectional view of a portion of a patient's vasculature, showing the delivery catheter of FIG. 5A being advanced through a patient's abdominal aorta.

FIG. 17 is a sectional view of a portion of a patient's vasculature, showing the delivery catheter of FIG. 5A and an angiographic catheter being advanced through a branch sheath of the delivery catheter toward a branch vessel.

FIG. 18 is a sectional view of a portion of a patient's vasculature, showing the delivery catheter illustrated in FIG. 5A and the branch sheaths of the delivery catheter being advanced into a patient's branch arteries.

FIG. 19 is a sectional view of a portion of a patient's vasculature, showing a distal sheath of the delivery catheter illustrated in FIG. 5A being advanced to deploy a proximal portion of the prosthesis.

FIG. 20 is a sectional view of a portion of a patient's vasculature, showing a peelable sheath of the delivery catheter illustrated in FIG. 5A being removed to deploy a distal portion of the prosthesis.

FIG. 21 is a sectional view of a portion of a patient's vasculature, showing a fenestration alignment component of the delivery catheter illustrated in FIG. 5A advancing an inner wall of the prosthesis adjacent to a fenestration toward an ostium of the target branch vessel.

FIG. 22 is a sectional view of a portion of a patient's vasculature, showing a branch stent being advanced into the target branch vessel.

FIG. 23 is a sectional view of a portion of a patient's vasculature, showing the branch stent of FIG. 22 being expanded in the target branch vessel and flared.

FIGS. 24A and 24B are oblique views of a prosthesis having one or more fenestrations therein, the graft being shown in dashed lines in FIG. 24B for clarity.

FIG. 25 is a top view of the prosthesis of FIG. 24.

FIG. 26 is an enlarged view of a portion of the prosthesis of FIG. 24, defined by curve 26-26 of FIG. 24B.

FIG. 27 is a side view of the stent shown in FIG. 24, perpendicular to an axis projecting through the fenestration.

FIG. 28 is a side view of the stent shown in FIG. 24, along an axis projecting through the fenestration.

FIG. 29 is an oblique view of a fenestration alignment component, which is also referred to herein as a fenestration alignment component.

FIG. 30 is a side view of the fenestration alignment component illustrated in FIG. 29.

FIG. 31A is an end view of the fenestration alignment component illustrated in FIG. 29.

FIG. 31B is a sectional view through a portion of the fenestration alignment component, taken at 31B-31B of FIG. 31A.

FIG. 32 is an oblique view of a delivery catheter having the fenestration alignment component of FIG. 29.

FIG. 33 is an exploded view of the delivery catheter shown in FIG. 32.

FIG. 34 is a sectional view of a portion of a patient's vasculature, showing the fenestration alignment component illustrated in FIG. 29 advancing an inner wall of the prosthesis adjacent to a fenestration toward an ostium of the target branch vessel.

DETAILED DESCRIPTION

In this description, reference is made to the drawings wherein like parts are designated with like numerals throughout the description and the drawings.

Some embodiments described herein are directed to systems, methods, and apparatuses to treat lesions, aneurysms, or other defects in the aorta, including, but not limited to, the thoracic, ascending, and abdominal aorta, to name a few. However, the systems, methods, and apparatuses may have application to other vessels or areas of the body, or to other fields, and such additional applications are intended to form a part of this disclosure. For example, it will be appreciated that the systems, methods, and apparatuses may have application to the treatment of blood vessels in animals.

As will be described, any of the graft embodiments disclosed herein can be configured to have excess or slack graft material in at least a portion thereof relative to the stent or support member which supports the graft. The excess or slack material can result from either an enlarged diametric portion of the graft, excess length of the graft material relative to a stent or other support structure, or a combination of both the enlarged diametric portion of the graft and excess length of the graft material. The excess graft material can form a bulge or other enlargement in the graft in the approximate location of one or more fenestrations formed through the graft material. The excess or slack material along the circumference of the graft (in the enlarged portion of the graft) can allow for circumferential and/or axial movement of the graft material and, hence, can allow for circumferential and/or axial movement of the one or more fenestrations, relative to the stent and the ostium of the patient's branch vessels. Therefore, the diameter of the graft at and/or adjacent to the location of one or more fenestrations through the graft material can be larger than the local diameter of the target vessel. Similarly, the diameter of the graft at and/or adjacent to the location of one or more fenestrations can be larger than the diameter of the non-enlarged portion of the graft material.

For example, any of the embodiments disclosed herein can be configured such that the graft has an enlarged or excess slack portion at or adjacent to the location of the fenestrations, wherein such enlarged or excess slack portion is free of attachment points or has only a minimal number of attachment points to the stent or support structure radially adjacent to the enlarged or excess slack portion. In some embodiments, this can result in both freedom of circumferential and axial movement of the fenestrations, thereby improving the positional adjustability of the fenestrations. The enlarged or excess slack portions of the graft can be radially unsupported by the stent or support member, or can be supported by a stent or support member or by connectors connecting support members positioned axially adjacent to the enlarged or excess slack portion. Accordingly, any of the graft embodiments described herein can be configured to have excess circumferential or longitudinal material at any portion of the graft to increase the positional adjustability of one or more fenestrations formed in the graft.

Further, any of the graft embodiments disclosed herein, including those with diametrically enlarged portions, can have excess graft material in an axial direction. The excess or slack material along the length of the graft can increase the circumferential and/or axial movement of the graft material adjacent to the one or more fenestrations formed in the graft material. Accordingly, the length of the graft material between the proximal and distal attachment points to the stent can be longer than that of the stent between the proximal and distal attachment points. Or, the graft material in a mid-portion of the graft, including on either side of the enlarged portion, can have an increased length relative to the stent adjacent to such graft portion.

FIG. 1 is a partial cross sectional view of a patient's vasculature illustrating an endoluminal prosthesis deployed in the desired position within the patient's vasculature.

As an example, FIG. 1 shows an endoluminal prosthesis deployed in a patient's aorta 10. An aneurysmal sac 10A is also shown. For reference, also illustrated are a patient's first and second renal arteries 12, 14, respectively, and a patient's ipsilateral and contralateral iliac arteries 16, 18, respectively. FIG. 2 is a side view of the endoluminal prosthesis 20 illustrated in FIG. 1. the endoluminal prosthesis 20 illustrated in FIGS. 1 and 2 has a main graft body 22, a first fenestration 24, and a second fenestration 26. The main graft is a bifurcated graft having a first bifurcated branch 28 and a second bifurcated branch 30 for placement in the ipsilateral and contralateral iliac arteries.

The main graft body 22 has a generally cylindrical, tubular shape. The endoluminal prosthesis 20 can be formed from any suitable material, such as, but not limited to, ePTFE. The endoluminal prosthesis 20 is formed from an expandable material. The endoluminal prosthesis 20 is formed such that the main graft body 22 can be sized to be larger than the target vessel into which the main graft body 22 is to be deployed. As illustrated in FIG. 1, the target vessel can be the aortic artery, and the endoluminal prosthesis can be deployed so as to span across an aneurysm in the abdominal aortic.

In any of the graft embodiments disclosed herein, the diameter of the graft body (such as without limitation the main graft body 22) or an enlarged portion of any embodiment of a graft body disclosed herein can be approximately 30% larger than the diameter of the target vessel or the diameter of the non-enlarged portion of the graft body. The diameter of the graft body (such as without limitation the main graft body 22) or an enlarged portion of any embodiment of a graft body disclosed herein can be less than approximately 20%, or from approximately 20% to approximately 50% or more, or from approximately 25% to approximately 40% larger than the target vessel or the diameter of the non-enlarged portion of the graft body, or to or from any values within these ranges.

Further, in any of the graft embodiments disclosed herein, at least a portion of the graft material adjacent to the one or more fenestrations or openings can be free to translate in a circumferential or axial direction relative to the stent that the graft is supported by. For example, particular portions such as the end portions of the graft material can be sutured or otherwise fastened to the stent, while a mid-portion of the graft having one or more fenestrations therethrough can be unattached to the stent so that such mid portion can be free to translate relative to the stent and, hence, permit the adjustability of the fenestrations relative to the stent. In this configuration, the fenestrations can be adjusted to align with the ostium of the patient's branch vessels.

As one non-limiting example, the diameter of the main graft body 22 configured for placement in an approximately 26 mm vessel can be approximately 34 mm in diameter. Therefore, the diameter of the main graft body 22 can be approximately 8 mm larger than the diameter of the target vessel. The diameter of the main graft body 22 can be between approximately 2 mm and approximately 14 mm, or between approximately 4 mm and approximately 12 mm, or between approximately 6 mm and approximately 10 mm larger than the diameter of the target vessel, or to or from any values within these ranges.

The oversized diameter of the main graft body 22 can provide excess or slack graft material in the main graft body 22 such that the fenestrations 24, 26 can each be moved in an axial, rotational, or angular direction, or a combination thereof to align the fenestrations 24, 26 with the branch vessels arteries, as will be described in greater detail below.

As described above, two or more fenestrations can be formed in the main graft body 22 at any desired location. With reference to FIG. 2, the two fenestrations 24, 26 can be formed at generally diametrically opposed locations. However, any number of fenestrations can be formed in the main graft body 22 at any desired locations. Additionally, scallops or cutouts can be formed in the distal end portion or at any suitable location in the main graft body 22, the scallops or cutouts being configured to prevent obstruction of other arteries branching off of the main vessel into which the main graft body 22 is to be deployed. For example, an additional fenestration 32 can be formed in a distal portion of the main graft body 22. The fenestration 32 can be formed so as to align with a patient's SMA

FIG. 3 is a cross-sectional view of the endoluminal prosthesis 20 deployed in the patient's anatomy, taken at 3-3 in FIG. 1, as it might appear before the fenestrations 24, 26 have become aligned with the respective branch vessels, for example renal arteries 12, 14. With reference to FIG. 3, the main graft body 22 (which can be oversized) has been deployed in the target vessel. After the main graft body 22 has been deployed in the target vessel, because the main graft body 22 can have a larger diameter than the vessel diameter, folds, wrinkles, or other undulations (collectively referred to as folds) 34 can form in the main graft body 22 about the circumference of the main graft body 22. The folds 34 can form in the main graft body 22 as a result of the fact that there can be excess or slack material in the main graft body 22 after the main graft body 22 has been deployed in the target vessel.

At least a portion of the main graft body 22 can have undulations, folds, bends, corrugations, or other similar features in the axial direction therein when the main graft body 22 is in a relaxed state (i.e., before the graft has been deployed). A middle portion of the graft can have undulations, folds, bends, corrugations or other similar features while the distal or upstream portion defines a smooth contour

FIG. 4 is a cross-sectional view of the endoluminal prosthesis 20 deployed in the patient's anatomy, taken at 3-3 in FIG. 1, after the fenestrations 24, 26 have become aligned with the respective branch vessels. With reference to FIG. 4, the oversized main graft body 22 is aligned with the patient's anatomy by the fenestration 24 following a angiographic or guide catheter over which it is threaded to align with the respective branch vessel as the main body is deployed, but after the branch vessel guidewires are positioned in the branch vessels. For example, the fenestration 24 as it moves closer to the fenestration 26, causes a gathering of slack material or folds 34 in a first portion 22a of the main graft body 22 and partially or fully removing the slack material or folds from a second portion 22b of the main graft body 22.

After the main graft body 22 has been positioned within the patient's anatomy such that the fenestrations 24, 26 have been aligned with the respective branch vessels, a covered stent, a bare wire stent, or any other suitable stent or anchoring device can be deployed within the main graft to secure the graft in the desired location (not illustrated). A bare metal stent deployed within the main graft body 22 can compress the folds 34 that are formed in the main graft body 22, if any, against the wall of the vessel and secure the main graft body 22 and the fenestrations 24, 26 in the desired locations.

Alternatively, a supra renal stent can be deployed at a distal or upper portion of the main graft body to secure the distal or upper portion of the main graft body in the desired location within the patient's vasculature, and one or more axial springs can be anchored to the main graft body to provide axial or column strength to the main graft body. The springs can have a helical shape, as illustrated, and can have any suitable size, length, pitch, or diameter. However, such helical shape is not required. The springs can have any suitable shape, including a straight, flat, round, or non-round shape. The springs can be formed from any suitable biocompatible material, such as without limitation stainless steel, Nitinol, or suitable metallic or polymeric materials.

Additionally, any of the features, components, or details of any of the graft, stents, or other apparatuses disclosed in U.S. patent application Ser. No. 12/496,446, filed on Jul. 1, 2009, entitled CATHETER SYSTEM AND METHODS OF USING SAME, U.S. patent application Ser. No. 12/390,346, filed on Feb. 20, 2009, entitled DESIGN AND METHOD OF PLACEMENT OF A GRAFT OR GRAFT SYSTEM, U.S. patent application Ser. No. 12/101,863, filed on Apr. 11, 2008, entitled BIFURCATED GRAFT DEPLOYMENT SYSTEMS AND METHODS, and U.S. Provisional Application 61/409,504, entitled APPARATUS AND METHOD OF PLACEMENT OF A GRAFT OR GRAFT SYSTEM, filed Nov. 2, 2010, can be used, with or without modification, in place of or in combination with any of the features or details of any of the grafts, stents, prostheses, or other components or apparatuses disclosed herein. Similarly, any of the features, components, or details of the delivery apparatuses and deployment methods disclosed in U.S. patent application Ser. Nos. 12/496,446, 12/390,346, and 12/101,863, can be used, with or without modification, to deploy any of grafts, stents, or other apparatuses disclosed herein, or in combination with any of the components or features of the deployment systems disclosed herein. The complete disclosures of U.S. patent application Ser. Nos. 12/496,446, 12/390,346, and 12/101,863 are hereby incorporated by reference as if set forth fully herein.

FIG. 5A is a side view of a catheter system 1000 comprising an introducer catheter 1002 (also referred to as an introducer) and a delivery catheter 1004. The delivery catheter 1004 can be configured for the delivery of an endoluminal prosthesis, including without limitation any endoluminal prosthesis embodiment disclosed herein or any other suitable prosthesis, or for any other suitable use.

FIG. 5B is an oblique view of a catheter system 1000 illustrated in FIG. 5A, showing an outer sheath 1006 of the delivery catheter 1004 in a partially retracted position. With reference to FIGS. 5A and 5B, the outer sheath 1006 can be used to constrain at least a portion of a prosthesis 1010. The prosthesis 1010 can have any of the same features, components, or other details of any of the other prosthesis embodiments disclosed herein, including without limitation the embodiments of the prosthesis 1200 described below. The prosthesis 1010 can have any number of stents or other support members, connectors, grafts, cuts, fenestrations, or other suitable components or features. As used herein, when referring to the prosthesis 1010, distal refers to the end of the prosthesis that is further from the patient's heart, and proximal refers to the end of the prosthesis that is closer to the patient's heart. As used herein with regard to the embodiments of the catheter system 1000, the term distal refers to the end of the catheter system that is further from the surgeon or medical practitioner using the catheter system, and the term proximal refers to the end of the catheter system that is closer to the surgeon or medical practitioner.

As illustrated in FIG. 5B, a distal sheath 1012 (also referred to herein as a first restraint or first restraining means) can be used to constrain a proximal portion of the stent graft 1010. The distal sheath 1012 can be supported by (connected to) a distal tip 1014 of the catheter system 1000. The distal tip 1014 can comprise an atraumatic material and design. As will be described in greater detail below, the distal tip 1014 and, hence, the distal sheath 1012 can be attached to an inner tube 1016 to control the position of the distal tip 1014 and the distal sheath 1012 relative to an inner core 1020 of the delivery catheter 1004. The inner core 1020 can be rotatable relative to the outer sheath 1006 so that a prosthesis supported by the delivery catheter 1004 can be rotated during deployment. The inner tube 1016 can be slidably positioned coaxially within a lumen in an outer tube 1018 that can connect a support member 1022 to the inner core 1020. The outer tube 1018 can be connected to an opening or partial lumen 1019 in the inner core 1020 so as to be axially and rotationally fixed to the inner core 1020.

In this configuration, the catheter system 1000 can be configured such that advancing the inner tube 1016 relative to an inner core 1020 of the delivery catheter 1004 causes the distal sheath 1012 to advance relative to the prosthesis 1010, causing the proximal portion of the prosthesis 1010 to be deployed. The prosthesis 1010 (or any other prosthesis disclosed herein) can be at least partially self-expanding such that, as the tubular distal sheath 1012 is advanced relative to the prosthesis 1010, a proximal portion of the prosthesis 1010 expands against a vessel wall. In some embodiments, only some segments or portions of the prosthesis 1010 such as, portions of the prosthesis axially adjacent to enlarged graft portions of the prosthesis, can be configured to be self-expanding.

The inner core 1020 can be slidably received within the outer sheath 1006 of the delivery catheter 1004. As in the illustrated embodiment, the outer sheath 1006 of the delivery catheter 1004 can be longer than an introducer sheath 1008 of the introducer catheter 1002. Further, a clip 1007 can be supported by the outer sheath 1006 to limit the range of axial movement of the outer sheath 1006 relative to the introducer catheter 1002.

Although not required, a core assembly 1021 can be connected to a proximal end portion of the inner core 1020, the core assembly 1021 having a reduced cross-sectional profile so as to permit one or more sheath members, fenestration alignment components (also referred to herein as fenestration alignment components), or other tubular or other components to pass through the main body of the delivery catheter 1004 and be advanced into one or more lumen within the inner core 1020. The inner core 1020 can be configured to accommodate the insertion of such sheath members, fenestration alignment components, or other tubular components into the lumen of the inner core 1020.

In the illustrated embodiment, a proximal end portion of the core assembly 1021 can comprise a handle member 1023 that is positioned outside a proximal end portion of the delivery catheter 1004 so as to be accessible by a user. The handle member 1023 can be configured to permit a user to axially or rotationally adjust the position of the inner core 1020 relative to the outer sheath 1006.

As discussed above, the inner core 1020, or components axially connected to the inner core 1020 such as the core assembly 1021, can extend proximally past the proximal end portion 1004a of the delivery catheter system 1004 so that a user can adjust and/or change the axial and/or radial position of the inner core 1020 and, hence, the prosthesis 1010, relative to the outer sheath 1006. Similarly, the inner tube 1016 can extend proximally past the proximal end portion 1004a of the delivery catheter 1004 and a proximal end portion 1021a of the core assembly 1021 so that a user can adjust and change the position of the inner tube 1016 relative to the inner core 1020.

In the partially retracted position of the outer sheath 1006 illustrated in FIG. 5B, at least a portion of the prosthesis 1010 supported by the catheter system 1000 can be exposed and, potentially, deployed. A distal portion of the prosthesis 1010 can be exposed and deployed by retracting the outer sheath 1006 relative to the inner core 1020 or distally advancing the inner core 1020 relative to the outer sheath 1006, causing at least a portion of the distal portion of the prosthesis 1010 to self-expand. As will be described, the prosthesis 1010 can be configured to have radially self-expanding support members therein along only a portion or portions of the prosthesis 1010. For example, a graft of the prosthesis 1010 can be radially unsupported at or adjacent to fenestrations formed in the graft. Alternatively, at least the distal portion of the prosthesis 1010 can be constrained within a sheath, such as a peelable sheath. Embodiments of the sheath will be described in greater detail below.

The delivery catheter 1004 can also have one or more branch or guide sheaths 1024 supported thereby. The delivery catheter 1004 can have three or more branch sheaths 1024. Such a configuration can be used for deploying branch stents into one or more branch vessels in the thoracic aorta. Each of the one or more branch sheaths 1024 can be configured to be slidably supported within one or more lumen 1025 formed in the inner core 1020 so that each of the one or more branch sheaths 1024 can be axially advanced or retracted relative to the inner core 1020. Further, the delivery catheter 1004 can be configured such that the branch sheaths 1024 can be rotationally adjusted or twisted relative to the inner core 1020. In some embodiments, each branch sheath 1024 can be positioned within the delivery catheter 1004 such that, in the loaded configuration wherein a prosthesis 1010 is supported (compressed) within the delivery catheter 1004, each branch sheath 1024 is pre-positioned so as to be advanced through a fenestration or branch graft of the prosthesis 1010. Each branch sheath 1024 can be positioned within the delivery catheter 1004 such that a distal end portion of each branch sheath 1024 projects past an end portion of the inner core 1020 and is constrained within the outer sheath 1006. As illustrated in FIGS. 5A-5B, in this configuration, the distal end portion of each branch sheath 1024 can be exposed by retracting the outer sheath 1006 relative to the inner core 1020 and/or the branch sheaths 1024.

Additionally, with reference to FIG. 5B, although not required, the delivery catheter 1004 can have one or more fenestration alignment components 1026 supported thereby. The one or more fenestration alignment components 1026 can be slidably received within one or more lumen 1027 formed in the inner core 1020. The one or more fenestration alignment components 1026 can each have an end portion 1026a that can be sized and configured to surround an outer surface of each of the branch sheaths 1024. The end portion 1026a of each fenestration alignment component 1026 can have, an open or closed annular or circular shape and can be of sufficient size and stiffness to permit a user to engage a fenestration or branch graft formed in or supported by a main body of the prosthesis 1010. For example, as will be described in greater detail below, after the main body of the prosthesis 1010 has been released from the outer sheath 1006 and any other radial restraints, a user can independently or collectively axially advance the fenestration alignment component 1026 over the branch sheaths 1024 such that the end portion 1026a of each fenestration alignment component 1026 contacts the edge or surface adjacent to and surrounding the fenestration or branch graft of the prosthesis 1010 and pushes the fenestration or branch graft toward an ostium of the target branch vessel of the patient's vasculature.

Accordingly, in this configuration, at least a portion of each of the one or more fenestration alignment components 1026 is configured to be slidably supported within a lumen formed in the inner core 1020 so that each of the one or more fenestration alignment components 1026 can be axially advanced relative to the inner core 1020. Further, the delivery catheter 1004 can be configured such that the fenestration alignment components 1026 can be axially or rotationally adjusted or twisted relative to the inner core 1020, for increased maneuverability of the fenestration alignment components 1026.

In some embodiments, each fenestration alignment component 1026 can be positioned within the delivery catheter 1004 such that, in the loaded configuration wherein a prosthesis 1010 is supported (compressed) within the delivery catheter 1004, each fenestration alignment component 1026 is pre-positioned so that the end portion 1026a of each fenestration alignment component 1026 is positioned distal to the end portion of the inner core 1020. In the loaded configuration, each fenestration alignment component 1026 can be positioned such that the end portion 1026a of each fenestration alignment component 1026 is located within the main lumen of the main body of the prosthesis 1010.

The branch sheaths 1024 and fenestration alignment components 1026 can have any suitable size and can be made from any suitable material. For example, the branch sheaths 1024 can have an approximately 6.5 French diameter, or from an approximately 5 Fr diameter or less to an approximately 8 Fr diameter or more, or to or from any values within this range. The fenestration alignment components 1026 can be formed from stainless steel, Nitinol, or any other suitable metallic or non-metallic material, and can have a thickness suitable to prevent the fenestration alignment components 1026 from buckling when axially advanced against a portion of the prosthesis 1010. For example, the fenestration alignment components 1026 can have an approximately 1 Fr diameter, or between approximately a 1 Fr and approximately a 4 Fr diameter. Further, the fenestration alignment component or catheters can be formed from a 0.035 in guidewire or otherwise have a 0.035 in diameter.

Additionally, as will be described below in greater detail, the catheter system 1000 can be configured such that the distal sheath 1012 can be advanced relative to the inner core 1020 and the prosthesis 1010, to expose a proximal portion of the prosthesis 1010. In particular, advancing the distal sheath 1012 can be accomplished by advancing the inner tube 1016 connected to the distal tip 1014 and the distal sheath 1012, so that the distal sheath 1012 releases the proximal portion of the prosthesis 1010. Other details regarding the distal sheath 1012 or methods of using the distal sheath can be found in U.S. Pat. No. 6,953,475, which application is incorporated by reference as if fully set forth herein.

FIGS. 6 and 7 are oblique and exploded views, respectively, of the introducer catheter 1002 shown in FIG. 5A. The introducer catheter 1002 can have any of the features or components of any of the embodiments disclosed in U.S. patent application Ser. No. 12/496,446, which disclosure is hereby incorporated by reference as if set forth herein. With reference to FIGS. 6-7, the introducer 1002 can have a main body 1030, a threadably engageable hub portion 1032, a threaded cap 1034 configured to threadably engage with a threaded distal end portion 1030a of the main body 1030 so as to secure the outer sheath 1006 to the main body 1030. The outer sheath 1006 can have a flanged end portion 1036 secured thereto or integrally formed therewith. The main body 1030 can support a seal assembly 1040 therein to seal around the inner core 1020 of the delivery catheter 1004 and/or other components of the catheter system 1000. A threaded end member 1042 having a threaded proximal end portion 1042a can be supported by the main body 1030. An annular seal member 1046 can be supported by the main body 1030 of the introducer catheter 1002. The introducer catheter 1002 can be configured such that the seal member 1046 can be adjusted to provide an additional seal around the inner core 1020 of the delivery catheter 1004 by threadably engaging the hub portion 1032. The seal assembly 1040 and seal member 1046 can have any of the details, features, or components of any of the embodiments of the introducer catheter described in U.S. patent application Ser. No. 12/496,446, which application is incorporated by reference as if fully set forth herein.

A tube assembly 1048 can be supported by the main body 1030 of the introducer catheter 1002 so as to provide an orifice or access port into the main body 1030. The tube assembly 1048 can be used to flush the introducer catheter 1002 with saline or other suitable substances at any stage, such as but not limited to prior to the advancement of an endoluminal prosthesis through the introducer catheter 1002 and/or delivery catheter 1004, or prior to other procedures for which another type of delivery catheter may be used. The tube assembly 1048 can support any suitable medical connector and/or valve on the distal end thereof.

FIGS. 8 and 9 are oblique and exploded views, respectively of the delivery catheter 1004 shown in FIG. 5A. FIG. 10 is a sectional view of a portion 10-10 of the delivery catheter 1004 shown in FIG. 5A. FIG. 11A is a sectional view of the delivery catheter 1004 shown in FIG. 5A, taken at 11A-11A shown in FIG. 10. FIG. 11B is a sectional view of the delivery catheter 1004 shown in FIG. 5A, taken at 11B-11B shown in FIG. 10.

As shown therein, the delivery catheter 1004 can have a main body 1050 that can support the inner core 1020 and/or core assembly 1021, one or more access ports 1052 for the one or more branch sheaths 1024, and one or more access ports 1054 for the one or more fenestration alignment components 1026. The access ports 1052, 1054 can be configured to sealingly tighten around the branch sheaths 1024 or the fenestration alignment components 1026, and to constrict around the branch sheaths 1024 or the fenestration alignment components 1026 so as to substantially axially secure the branch sheaths 1024 or the fenestration alignment components 1026. A sealable cap assembly 1051 can be threadably engaged with the main body 1050 of the delivery catheter 1004. The cap assembly 1051 can be configured such that, when a user tightens the cap assembly 1051 relative to the main body 1050 of the delivery catheter 1004, the core assembly 1021 and/or inner core 1020 will be axially and/or rotational secured to the main body 1050 of the delivery catheter 1004.

A tube assembly 1059 can be supported by the main body 1050 of the delivery catheter 1004 so as to provide an orifice or access port into the main body 1050. The tube assembly 1059 can be used to flush the delivery catheter 1004 with saline or other suitable substances. The tube assembly 1059 can support any suitable medical connector and/or valve on the distal end thereof.

As mentioned above, the support member 1022 can be connected to a distal end portion of the outer tube 1018 so as to be axially engaged by the outer tube 1018. The support member 1022 can have a substantially cylindrical shape and can be sized to fit within the inner lumen of a main body of the prosthesis 1010 when the prosthesis 1010 is in a constrained configuration. As will be described, in the loaded configuration, the prosthesis 1010 can be positioned over the support member 1022 so that a proximal portion of a main body of the prosthesis 1010 is positioned distally of the support member 1022 and so that a distal portion of a main body of the prosthesis 1010 is positioned proximally of the support member 1022. In this configuration, a proximal end portion 1012a of the distal sheath 1012 can be positioned over a distal portion 1022a of the support member 1022, and a distal end portion 1006a of the outer sheath 1006 over a proximal portion 1022b of the support member 1022.

In some embodiments, one or more tab members 1074 can be supported by the outer tube 1018. The one or more tab members 1074 can be configured to increase the rotational engagement of the constrained prosthesis 1010 relative to the outer tube 1018 so that the constrained prosthesis 1010 can be rotated with greater accuracy during deployment. The one or more tab members 1074 can have a generally flat, plate-like shape, such as is illustrated in FIG. 8. The one or more tab members 1074 can be formed from a suitable polymeric or metallic material. The one or more tab members 1074 can comprise one or more radiopaque features or be formed from a radiopaque material to improve the visibility and alignability of the delivery catheter 1004 under fluoroscopy during deployment of the prosthesis 1010.

The one or more tab members 1074 can be similar to any of the embodiments of the torsion tab (such as the torsion tab 196) disclosed in U.S. patent application Ser. No. 12/101,863, which disclosure is incorporated by reference as if fully set forth herein. The one or more tab members 1074 can be integrally formed with the outer tube 1018, or secured thereto such as by thermal bonding, adhesive bonding, and/or any of a variety of other securing techniques known in the art.

As is illustrated, the main body portion of the prosthesis 1010 can be constrained by a peelable sheath or by the outer sheath 1006 such that the prosthesis 1010 is engaged with the one or more tab members 1074. The one or more tabs 1074 can engage a stent or other portion of an endoskeleton of the prosthesis 1010, or, can engage the material of the graft 1204 surrounding the tab member 1074 so that the prosthesis 1010 can substantially rotate with the inner core 1020 of the deployment catheter 1004.

FIG. 12 is a side view of the catheter system 1000 showing the outer sheath 1006 in a partially retracted position, similar to the configuration shown in FIG. 5B. FIG. 13 is an enlarged side view of the portion 13-13 of the catheter system shown in FIG. 12.

With reference to FIG. 13, the mid portion of the prosthesis 1010 adjacent to the one or more fenestrations 1011 and/or the distal portion 1010a of the prosthesis can be constrained within a peelable sheath 1060. The peelable sheath 1060 can have a release wire 1062 threadably advanced through a plurality of openings 1064 formed along at least a portion of the sheath 1060. The peelable sheath 1060, release wire 1062, and openings 1064 can have any of the same features, materials, or other details of the similar components disclosed in U.S. patent application Ser. No. 12/101,863, which application is incorporated by reference as if fully set forth herein. The release wire 1062 can be slidably received within a lumen in the inner core 1020 so that a user can retract the release wire 1062 by grasping and retracting a proximal portion of the release wire 1062 positioned outside the patient's body.

However, the mid portion of the prosthesis 1010 adjacent to the one or more fenestrations 1011 and/or the distal portion 1010a of the prosthesis can be constrained within one or more tubular sheaths, such as the outer sheath 1006 (also referred to herein as a second restraint or second restraining means) and/or distal sheath 1012 such that additional restraining means such as the sheath 1060 are not required (not illustrated). Therefore, any of the embodiments disclosed herein having the optional sheath 1060 should be understood to be configurable to not use the sheath 1060 to restrain one or more portions of the prosthesis 1010. The prosthesis 1010 can be configured such that the mid portion of the prosthesis 1010 adjacent to the one or more fenestrations 1011 is not radially supported by a stent, connectors, struts, or any other similar structure such that, when the outer sheath 1006 is partially retracted, the mid portion of the prosthesis does not self-expand.

The prosthesis 1010 can have one or more openings 1011 formed therein. For example and the fenestrations or openings 1011 can be formed in the prosthesis 1010 at diametrically opposing positions. As will be described in greater detail below, one or more of the openings 1011 can be formed in the prosthesis 1010 at a position that is angularly offset from the diametrically opposing position. Similarly, when used, the sheath 1060 can have one or more openings 1061 formed therein, the openings 1061 being positioned adjacent to the similar number of openings 1011 formed in the prosthesis. The catheter system 1000 can be configured such that the sheaths 1024 are advanced through the openings 1011 formed in the prosthesis 1010 and the openings 1061 formed in the sheath 1060, when the prosthesis 1010 is loaded within the catheter system 1000.

With reference to FIG. 11B, due to the non-uniform design of the stent within the graft material, the prosthesis 1010 can be efficiently packed within the outer sheath 1006 so as to surround the sheaths 1024 and efficiently fill the space within the outer sheath 1006. In this configuration, for example, the prosthesis 1010 can be loaded within the outer sheath 1006 so that the sheaths 1024 are advanced between many of the struts, bends, loops, and other features that the stent can comprise, thereby permitting the sheaths 1024 sufficient space to be loaded within the outer sheath 1006 so that the lumen of the sheaths 1024 are not compressed or collapsed in the loaded state. Additionally, the graft can be formed from a bi-directionally expanded, layered PTFE material have thin walls to further increase the space efficiency of the prosthesis 1010.

As illustrated in FIG. 13, where used, the peelable sheath 1060 can have one or more release wires 1062 (two being shown) advanced through openings or perforations 1064 formed in the sheath 1060 along two sides of the sheath 1060. The release wires 1062 can be configured to tear the sheath 1060 along two lines of perforations 1064 and/or scores formed along two sides of the sheath 1060, so that the sheath 1060 can be removed from the prosthesis 1010 while the sheaths 1024 are advanced through the fenestrations 1011, 1061, respectively, in the prosthesis 1010 and sheath 1060. In this configuration, each of the two release wires 1062 can be secured to a proximal end portion 1060a of the sheath 1060, so that both halves of the sheath 1060 can be retracted through the outer sheath 1006.

However, as illustrated in FIG. 14, the catheter system 1000 can be configured to only have one release wire 1062 threadably advanced through the sheath 1060. FIG. 14 is an enlarged side view of the catheter system 1000 shown in FIG. 5A, defined by curve 14-14 shown in FIG. 12, showing the outer sheath 1006 in a partially retracted position and the distal sheath 1012 in a partially advanced position.

The perforations 1064 formed in the sheath 1060 can be arranged along an axial line along the length of the portion of the sheath 1060 from the fenestrations 1061 to the distal end of the sheath 1060, and also arranged to split the sheath 1060 between the two fenestrations 1061 formed in the sheath 1060. As illustrated in FIG. 14, the perforations 1064 formed in the sheath 1060 arranged along the length of the sheath 1060 can be positioned to tear the sheath 1060 from one of the fenestrations 1061 to the distal end 1060b of the sheath 1060, and also to circumferentially tear the sheath 1060 between the fenestrations 1061.

As mentioned above, with reference to FIG. 14, the catheter system 1000 can be configured such that a proximal portion 1010b of the prosthesis 1010 can be deployed by axially advancing the inner tube 1016 relative to the inner core 1020 of the delivery catheter 1004 and, hence, the prosthesis 1010. The prosthesis 1010 can be self-expanding such that removing the radial constraint provided by the distal sheath 1012 can cause the portion of the prosthesis 1010 constrained by the inner tube 1016 to expand toward the vessel wall. The proximal portion 1010b of the prosthesis 1010 can be deployed in this manner before the distal portion 1010a of the prosthesis 1010 is deployed, or simultaneously with the deployment of the distal portion 1010a of the prosthesis 1010. The proximal portion 1010b of the prosthesis 1010 can be deployed in this manner after the distal portion 1010a of the prosthesis 1010 is deployed.

FIG. 15 is a side view of the catheter system 1000 shown in FIG. 5A, showing the outer sheath 1006 in a partially retracted position and one branch sheath 1024′ and one fenestration alignment component 1026′ in a partially advanced position. The branch sheath 1024′ can be advanced relative to the inner core 1020, the prosthesis, and the second branch sheath 1024″ by advancing a proximal portion of the branch sheath 1024′ in the direction of arrow A1 in FIG. 15 through the access port 1052′ at the proximal end of the delivery catheter 1004. Similarly (not shown), the second branch sheath 1024″ can be advanced relative to the inner core 1020, the prosthesis, and the first branch sheath 1024′ by advancing a proximal portion of the branch sheath 1024″ through the access port 1052″ at the proximal end of the delivery catheter 1004. Additionally, either of the fenestration alignment components 1026′, 1026″ can be advanced relative to the branch sheaths 1024′, 1024″ by advancing the respective fenestration alignment component 1026 through the respective access port 1054. For example, the fenestration alignment component 1026′ can be advanced by advancing the proximal portion of the fenestration alignment component 1026′ in the direction of arrow A2 in FIG. 15.

With the embodiments of the catheter system 1000 having been described, several configurations of deployment methods for an endoluminal prosthesis, including any suitable prosthesis or any endoluminal prosthesis disclosed herein, will now be described with reference to FIGS. 16-23. FIG. 16 is a sectional view of a portion of a patient's vasculature, showing the delivery catheter 1000 being advanced through a patient's abdominal aorta over a guidewire 1070 positioned within a patient's vasculature. As in the illustrated embodiment, the delivery catheter 1000 can be advanced through a prosthesis 1080 (which can be a bifurcated prosthesis) deployed within the patient's vasculature.

FIG. 17 is a sectional view of a portion of a patient's vasculature, showing the delivery catheter 1000 and an angiographic catheter 1065 being advanced through a branch sheath 1024 of the delivery catheter toward a target branch vessel. As illustrated, an outer sheath 1006 of the catheter system 1000 has been retracted relative to the inner core (not shown) and the prosthesis 1010, exposing a middle portion of the prosthesis 1010 (i.e., a portion of the prosthesis 1010 radially adjacent to the one or more fenestrations 1011) and the branch sheaths 1024a, 1024b. After the branch sheaths 1024a, 1024b have been exposed, a suitable angiographic catheter 1065 can be advanced through the lumen of either or both of the branch sheaths 1024a, 1024b and directed into the target branch vessel or vessels. A user can rotate the inner core 1020 to approximately rotationally align the fenestrations 1011 of the prosthesis 1010 or the branch sheaths 1024 with the branch vessels.

As discussed above, the optional sheath 1060 can constrain the mid and distal portions of the prosthesis 1010 such that, when the outer sheath 1006 is retracted, the mid and distal portions of the prosthesis 1010 do not self-expand. However, the mid portion of the prosthesis 1010 radially adjacent to the one or more fenestrations 1011 can be unsupported by any stents 1254. In this configuration, the prosthesis 1010 can be configured such that there is no radial force or support provided to the mid portion of the prosthesis 1010, or such that the mid portion of the prosthesis 1010 will not be biased to self-expand when the outer sheath 1006 is retracted. Accordingly, some embodiments can be configured such that no additional restraint in addition to, for example, the outer sheath 1006, is required. Therefore, only the outer sheath 1006 and the distal sheath 1012 can be used to restrain the prosthesis 1010. In this configuration, the outer sheath 1006 can be partially retracted to release the sheaths 1024 so that one or more angiographic catheters 1065 can be advanced through the sheaths 1024 and into the target branch vessels before the proximal and distal portions of the prosthesis 1010 are released from the deployment catheter 1004.

The angiographic catheter 1065 can be configured such that an end portion thereof is biased to have a curved disposition (shape), as is well known in the art.

As shown, an angiographic catheter 1065 is being advanced relative to the branch sheath 1024a and into the target branch vessel, in this case a renal artery. The delivery catheter 1000 can be configured such that an angiographic catheter can be advanced through the desired branch sheath 1024 and into the target vessel without retracting the outer sheath 1006. After the angiographic catheters 1065 have been directed into the target location, in this case the branch vessels, either or both of the branch sheaths 1024 can be independently or simultaneously advanced over the angiographic catheters 1065 into the target branch vessels, as is illustrated in FIG. 18. The branch sheaths 1024, the fenestrations 1011, 1061 formed in either the prosthesis 1010 or the sheath 1060, respectively, and/or any other components or features of the delivery catheter 1000 can have radiopaque markers or other indicators to assist a medical practitioner in the deployment procedures described herein or other suitable deployment procedures.

With the branch sheaths 1024 in the target vessels and the outer sheath 1006 axially retracted, as shown in FIG. 19, a proximal portion 1010b of the prosthesis 1010 can be deployed by axially advancing the distal sheath 1012 relative to the inner core 1020 and the prosthesis 1010. The prosthesis 1010 can be axially and rotationally secured to the outer tube 1018, which can be axially and rotationally secured to the inner core 1020, such that advancing the distal sheath 1012 relative to the inner core 1020 will advance the distal sheath 1012 relative to the prosthesis 1010. As described above, the distal sheath 1012 can be advanced relative to the inner core 1020 and the prosthesis 1010 by advancing the inner tube 1016 relative to the inner core 1020, the inner tube 1016 being axially engaged with the distal tip 1014 which can support the distal sheath 1012.

FIG. 20 is a sectional view of a portion of a patient's vasculature, showing a peelable sheath 1060 being removed from the distal portion 1010a of the prosthesis 1010 so as to deploy a distal portion 1010a of the prosthesis 1010. The sheath 1060 can be removed by axially retracting a release wire 1062, which can be looped or other otherwise threaded through openings or perforations 1064 formed in the sheath material. The release wire 1062 can be configured to tear through the sheath material between the perforations 1064, thereby permitting the self-expanding prosthesis 1010 to expand toward the vessel walls. As mentioned, the prosthesis 1010 can be configured to be restrained within the outer sheath 1006 and the distal sheath 1012 such that an additional restraint, such as the peelable sheath 1060, is not required.

As illustrated, a distal portion 1060a of the sheath 1060 can be torn by the release wire 1062 before a proximal portion 1060b of the sheath 1060 is torn by the release wire so that a proximal portion 1010b of the prosthesis (i.e., adjacent to the proximal portion 1060a of the sheath 1060) can be deployed before a distal portion 1010a of the sheath 1010. A proximal portion 1060b or a middle portion of the sheath 1060 can be torn by the release wire 1062 before a distal portion 1060a of the sheath 1060 is torn by the release wire (not illustrated). The release wire 1062 can be secured to the proximal portion 1060b or other suitable portion of the sheath 1060 such that, after the sheath 1060 has been torn, the sheath 1060 can be removed through the delivery catheter 1000 by continuing to axially retract the release wire 1062 relative to the prosthesis 1010.

As illustrated, a distal portion 1010a of the prosthesis 1010 (i.e., the downstream portion of the prosthesis 1010) can be deployed within an opening of an adjacent prosthesis, such as without limitation the bifurcated prosthesis 1080 illustrated in FIG. 20. However, the delivery catheter 1000 or any other delivery catheter described herein can be used to deploy any suitable prosthesis, including a bifurcated prosthesis or otherwise, in any portion of a patient's vasculature. As such, the prosthesis 1010 can be a bifurcated prosthesis.

FIG. 21 is a sectional view of a portion of a patient's vasculature, showing a fenestration alignment component 1026 contacting and pushing an inner wall of the prosthesis 1010 adjacent to a fenestration 1011 toward an ostium of the target branch vessel. As illustrated, the fenestration alignment component 1026 can be advanced through a lumen in the inner core 1020 to push the fenestration 1011 of the prosthesis 1010 over the branch sheath 1024 and into approximate alignment with the ostium of the branch vessel. The catheter system 1000 can be configured to not have a fenestration alignment component 1026, and can accordingly be configured to deploy a fenestrated graft without the use of such a component

As illustrated in FIG. 22, a covered or uncovered branch stent 1084 can be deployed in the branch vessel by advancing the branch stent 1084 through the branch sheath 1024 using a suitable catheter, such as a renal stent catheter, into the target vessel, after the angiographic catheter has been removed from the branch sheath 1024. The stent 1084 can be supported on an inflation balloon 1086, which can be supported by a guidewire 1088. The guidewire 1088 can be configured to have an inflation lumen therein, to inflate the balloon 1086 and expand the branch stent 1084 in the target location after the branch sheath 1024 has been at least partially retracted so as to not interfere with the expansion of the branch stent 1084, as illustrated in FIG. 23. The inflation balloon 1086 can be configured to expand and flare a portion of the stent 1084 within or to the inside of the fenestration 1011 formed in the prosthesis.

The fenestration alignment component 1026 described above can be configured to be supported within a renal or branch stent delivery catheter. For example, the fenestration alignment component 1026 can be configured to be supported within a modified renal stent catheter, such as the renal stent catheter illustrated in FIG. 22. The fenestration alignment component 1026 can be configured to only partially surround the branch sheath 1024 or the branch stent delivery catheter. In this configuration, the fenestration alignment component 1026 can be configured to be entirely positioned within and advanceable through a lumen of the branch sheath 1024 or the branch stent delivery catheter. For example, the fenestration alignment component 1026 can have an expandable end portion that can automatically expand when the end portion is advanced past the end of the lumen, so as to enable the end portion to snare or engage the graft material surrounding the fenestration.

Additionally, the branch stent delivery catheter can be configured to have a snare, protrusion, or other object tethered to the balloon or stent, or to be projecting from an outside surface thereof to snare or engage the graft material adjacent to the fenestration, so as to cause the fenestration to be advanced toward the ostium as the branch stent delivery catheter is advanced through the fenestrations. For example, the branch stent delivery catheter can have a biased wire member supported on an outside surface of the branch stent delivery catheter that is biased to expand when the wire member is advanced past the end of the branch sheath 1024. The wire member can expand to a size that is larger than the size of the fenestration. The wire member can be supported at a position that is offset from an end of the branch stent delivery catheter.

The fenestration 1011 in the prosthesis 1010 can expand as the branch stent 1084 is being expanded, to improve the seal between the fenestration 1011 and the branch stent 1084. A second expansion balloon can be positioned in the portion of the stent 1084 within or to the inside of the fenestration 1011 to flare that portion of the stent 1084, either with or without removing the first balloon used to expand the main portion of the branch stent 1084.

Some arrangements are directed to methods of deploying an endoluminal prosthesis, such as without limitation the prosthesis 1010 described above, comprising inserting a delivery catheter such as catheter system 1000 into an artery, exposing one or more branch sheaths 1024, advancing one or more angiographic catheters having one or more guidewires into the one or more branch sheaths 1024 and cannulating the target branch vessels, advancing the one or more branch sheaths 1024 over the angiographic catheters and into the target branch vessels, advancing the wall of the prosthesis adjacent to each of one or more fenestrations in the prosthesis toward the ostium of the target branch vessels, removing the one or more angiographic catheters and/or guidewires, inserting one or more branch stents into the branch vessels, retracting the branch sheaths, expanding the branch stents, and flaring a portion of the branch stents. In some arrangements, the target branch vessels are the renal arteries. Some arrangements also comprise deploying a proximal and distal portion of the prosthesis. The steps of the foregoing procedure can be performed in the sequence described, or can be performed in any suitable sequence.

embodiments are directed to apparatuses for placing a prosthesis across at least one branch vessel, the prosthesis having a distal end, a proximal end, a midsection, and at least one lateral opening in the midsection of the prosthesis. The prosthesis can be constrained in a delivery system having a distal and a proximal end. The apparatus can comprise a catheter extending from the proximal end of the delivery system through the lateral opening in the prosthesis, wherein a guidewire can be passed from the proximal end of the delivery system through the catheter, into the branch vessel with at least the proximal and distal ends of the prosthesis remaining constrained in the delivery system. The prosthesis can be a stent graft.

FIGS. 24A and 24B are oblique views of a prosthesis 1200 comprising one or more fenestrations 1202 formed in the graft 1204, and a stent or support member 1206. the graft 1204 is shown in dashed lines in FIG. 24B for clarity. The prosthesis 1200 can have any of the features, components, or other details of any other prosthesis embodiments disclosed herein such as, prosthesis 1010 described above. Further, any of the features of the prosthesis 1200 can be used in combination with any of the other prosthesis embodiments disclosed herein.

The graft 1204 can be supported by the stent 1206 along at least a portion of the graft 1204. Further, the graft 1204 can be overlapped and can have stitching or sutures 1208 along one or more edges of the graft 1204, which can improve the tear resistance of the graft 1204 and can improve the connection between the graft 1204 and the stent 1206.

Similar to other graft embodiments described herein, the graft 1204 can be configured to have excess or slack graft material in at least a portion thereof relative to the stent which supports the graft. For example, the excess graft material can form a bulge or other enlargement in the graft 1204 in the approximate location of one or more fenestrations 1202 formed through the graft material. The excess or slack material along the circumference of the graft 1204 (for example, in the enlarged portion 1204a of the graft 1204) can allow for circumferential and/or axial movement of the graft material and, hence, the one or more fenestrations 1202, relative to the stent 1206 and the ostium of the patient's branch vessels. Therefore, the diameter of the graft 1204 at and/or adjacent to the location of one or more fenestrations 1202 can be larger than the local diameter of the target vessel. Similarly, the diameter of the graft 1204 at and/or adjacent to the location of one or more fenestrations 1202 can be larger than the diameter of the non-enlarged portion of the graft material. In some embodiments, the outside surface of the graft 1204 in the enlarged portion 1204a or otherwise can be free from any corrugations or other preformed folds, overlaps, or other similar pre-formed features.

Further, similar to any of the other graft embodiments disclosed herein, the graft 1204 can have excess graft material in an axial direction, in addition to or in the alternative of the diametrically enlarged portion. The excess or slack material along the length of the graft 1204 can increase the circumferential and/or axial adjustability or movement of the graft material adjacent to the one or more fenestrations 1202 formed in the graft 1204. Accordingly, the length of the graft material between the proximal and distal attachment points to the stent 1206 can be longer than that of the stent 1206 between the proximal and distal attachment points. Or, the graft material in a mid-portion of the graft 1204, including on either side of the enlarged portion 1204a, can have an increased length relative to the stent radially adjacent to such graft portion.

Further, the enlarged portion and/or excess length of the graft 1204 or any other graft embodiment disclosed herein can be free from any attachment points to the stent or support member which supports the graft 1204. In these configurations, the positional adjustability of the fenestrations can be increased because the graft material is free to move in an axial and/or circumferential direction relative to the stent and relative to the ostium of the target branch vessels. The enlarged portion and/or excess length of the graft 1204 or any other graft embodiment disclosed herein can be configured to have only a limited number of attachment points to the stent or support member which supports the graft 1204. The attachment points can be sufficiently away from the fenestration or opening so as to not substantially affect the adjustability of the fenestration. For example, the prosthesis 1010 can be configured such that the enlarged or slack portion of the graft has only a limited number of attachments to a stent or connector (such as connector 1254) away from the fenestrations 1202 so that the adjustability of the enlarged or slack portion is not significantly affected. For example, in embodiments having only one fenestration in the enlarged portion, the attachment or attachments to the stent or other support member can be positioned on an opposite side of the graft as compared to the position of the fenestration. In these configurations, the positional adjustability of the fenestrations can be increased because the graft material is substantially free to move in an axial and/or circumferential direction relative to the stent and relative to the ostium of the target branch vessels.

With reference to FIGS. 24A-25, the graft 1204 can have one or more enlarged portions 1204a having an enlarged diameter relative to the target vessel or relative to one or more non-enlarged portions of the graft 1204, such as portions 1204b, 1204c that can improve the radial and/or axial adjustability of the fenestrations 1202 formed in the enlarged portions 1204a to better accommodate asymmetrically positioned branch vessel ostium. In some embodiments, with reference to FIGS. 24A and 24B, the graft 1204 can have an enlarged middle portion 1204a having one or more fenestrations 1202 formed therein, a non-enlarged proximal portion 1204b, and a non-enlarged distal portion 1204c.

As discussed above, in the prosthesis 1200, the enlarged portion 1204a of the graft 1204 can have a diameter that is approximately 30% larger than a diameter of the target vessel or the diameter of the non-enlarged portions 1204b, 1204c of the graft 1204. The diameter of the enlarged portion 1204a of the graft 1204 can be from approximately 20% or less to approximately 50% or more, or from approximately 25% to approximately 40% larger than the target vessel or the diameter of the non-enlarged portions 1204b, 1204c of the graft 1204, or to or from any values within these ranges.

Additionally, the enlarged portion 1204a or portion of the graft 1204 adjacent to the enlarged portion 1204a of the graft 1204 can be sized and configured to be substantially longer (i.e., in the axial direction) than the stent 1206, which can improve the radial and/or axial adjustability of the fenestrations 1202 formed in the enlarged portions 1204a to better accommodate the asymmetric and/or non-uniform positioning of branch vessel ostium. The graft 1204 can be longer than the stent 1206 in both the enlarged portion 1204a of the graft 1204 and/or in the portion of the non-enlarged distal portion 1204c of the graft adjacent to the enlarged portion 1204a of the graft 1204. For example, the enlarged portion 1204a or portion of the graft 1204 adjacent to the enlarged portion 1204a of the graft 1204 can be sized and configured to be approximately 20% longer in the axial direction than the stent 1206. The enlarged portion 1204a or portion of the graft 1204 adjacent to the enlarged portion 1204a of the graft 1204 can be sized and configured to be from approximately 10% to approximately 40% or more longer in the axial direction than the stent 1206.

FIG. 25 is a top view of the prosthesis 1200 of FIG. 24. With reference to FIGS. 24-25, the prosthesis 1200 can have fenestrations 1202 formed in an enlarged portion 1204a of the graft 1204. The fenestrations 1202 can be formed at non-diametrically opposed positions. This can improve the alignment of the fenestrations 1202 with the ostium of the target branch vessels, which in general can be located at non-diametrically opposed positions. The fenestrations 1202 formed in either the enlarged portion or portions 1204a or non-enlarged portions 1204b, 1204c of the graft 1204, can be angled away from the diametrically opposed position (represented by angle X in FIG. 25) such that the fenestrations 1202 are separated by an angle (represented by angle Y in FIG. 25) that is less than 180 degrees.

For example, the graft 1204 can have two fenestrations 1202 formed at an angle away from the diametrically opposed position (represented by angle X in FIG. 25) of approximately 15 degrees such that the fenestrations 1202 are separated by an angle (represented by angle Y in FIG. 25) that is approximately 150 degrees. The graft 1204 can have two fenestrations 1202 formed at an angle away from the diametrically opposed position of between approximately 10 degrees or less and approximately 20 degrees or more, such that the fenestrations 1202 are separated by an angle (represented by angle Y in FIG. 25) that is between approximately 160 degrees and approximately 140 degrees.

The graft 1204 can have two fenestrations 1202 formed in an enlarged portion 1204a of the graft and wherein the fenestrations 1202 are separated by an angle that is less than 180 degrees, for example approximately 150 degrees. In this configuration, positioning the fenestrations 1202 to be separated by an angle that is less than 180 degrees (such as, for example, approximately 150 degrees) can improve the alignment of the fenestrations 1202 with the ostium of the target branch vessels such that the enlarged portion 1204a of the graft 1204 can be from approximately 20% to approximately 60% greater than the non-enlarged portion 1204b, 1204c of the graft 1204. In this configuration, the enlarged portion 1204a of the graft 1204 can be from approximately 20% to approximately 40% greater than the non-enlarged portion 1204b, 1204c of the graft 1204.

The graft 1204, which can be a bifurcated or other suitably configured graft, can have two fenestrations 1202 formed in an enlarged portion 1204a of the graft, wherein the fenestrations 1202 can be separated by an angle that is less than 180 degrees, and wherein the length of at least a portion of the graft 1204 can be substantially greater than the length of the stent 1206, for example approximately 10% greater than the length of the stent 1206. In this configuration, positioning the fenestrations 1202 to be separated by an angle that is less than 180 degrees (such as, for example, approximately 150 degrees) and increasing the length of the graft 1204 to be approximately 10% greater than the length of the stent 1206 can improve the alignment/alignability of the fenestrations 1202 with the ostium of the target branch vessels such that the enlarged portion 1204a of the graft 1204 can be from approximately 10% or less to approximately 20% greater than the non-enlarged portion 1204b, 1204c of the graft 1204.

With reference to FIGS. 24-25, though not required, the prosthesis 1200 can have reinforced fenestrations 1202 comprising a tubular member 1210 inserted through the fenestration 1202 and stitched to the graft 1204 with one or more sutures 1212. In this configuration, which will be described in greater detail below, the tubular member 1210 can improve the tear resistance of the fenestration 1202 and also improve the sealability between the fenestrations 1202 and the branch grafts and stents deployed within the fenestrations 1202 as well as the pull-out resistance of the branch grafts and stents within the fenestrations 1202. This configuration can reduce leakage between the fenestrations 1202 and the branch grafts and stents deployed within the fenestrations 1202. In some embodiments, this configuration can also increase the force required to pull the branch grafts and stents deployed within the fenestrations 1202 out of the fenestrations 1202, thereby reducing the inadvertent axial movement of the branch grafts and stents deployed within the fenestrations 1202.

With reference to FIGS. 24A and 24B, although not required, the graft 1204 can have a scallop or cut-away 1230 at a proximal end portion 1204b of the graft 1204. The cut-away 1230 can be sized and configured to permit unrestricted blood flow through a branch artery, such as the suprarenal and/or the celiac arteries. The size of the cut-away 1230 can be based on the anatomy of a patient, or can be sized to accommodate a wide range of vessel anatomies. The cut-away 1230 can have a length approximately equal to the length of two stent struts, such as stent strut 1246 described below. The graft 1204 can be overlapped and have stitching 1208 along an edge of the cut-away 1230. The prosthesis 1200 can have a flared proximal end portion to increase the sealability of such end portion of the prosthesis 1200.

As described above, the prosthesis 1200 can have one or more radiopaque markers, such as but not limited to the annular radiopaque marker 1222 surrounding at least a portion of the fenestration 1202, for improved visibility under fluoroscopy during deployment. Any of the radiopaque markers can be formed from gold or platinum, or any suitable material. Any of the radiopaque markers can be formed from a suitable non-reinforcing metallic material.

FIG. 27 is a side view of the stent 1206 shown in FIG. 24, viewed along a line that is perpendicular to an axis projecting through a fenestration formed in the graft 1204 (not shown). For clarity, the location of a fenestration 1202 is shown dashed lines. FIG. 28 is a side view of the stent 1206, viewed along an axis projecting through a fenestration. Again, for clarity, the location of a fenestration 1202 is shown dashed lines.

With reference to FIGS. 26 and 27-28, the stent 1206 can be formed from one or more wires forming a plurality of loops 1240, which can be closed loops or eyelets, bends 1242, and struts 1246. Some of the bends 1242 can be configured to slide along a portion of the length of a respective strut 1246, to improve the flexibility and bendability of the stent 1206. The positioning of the plurality of loops 1240 and bends 1242 can be longitudinally offset or staggered to decrease the collapsed diameter of the prosthesis 1200.

The stent 1206 can comprise a first stent segment 1250 formed from one or more lengths of wire, a second stent segment 1252 formed from one or more lengths of wire, and one or more connecting members 1254 formed from one or more lengths of wire. The first and second stent segments 1250, 1252 can be positioned proximally and distally relative to the location of the fenestration (shown in dashed lines) that can be formed in the graft (not illustrated) that can be supported by the stent 1206. The length of the first stent segment 1250 can be sufficient to result in an increased seal zone in the suprarenal portion of the aorta, such as a length that extends to a position adjacent to or overlapping the superior mesenteric artery and/or the celiac artery.

In some embodiments, two connecting members 1254 can be positioned between the first and second stent segments 1250, 1252, and can be sized and offset from one another to provide a significant gap around the position of the fenestrations 1202 to increase the accessibility and adjustability of the fenestrations 1202 during deployment of the prosthesis 1200. As illustrated, the connecting members 1254 can have four struts. The connecting members 1254 can have three or less struts, or can have five or more struts. The connecting members 1254 can have a first connecting member 1254 having fewer struts than a second connecting member 1254.

FIGS. 29-31 are oblique, side, and end views, respectively, of a fenestration alignment component 2026 (also referred to as a push member or alignment device) that can be used in any of the delivery catheter embodiments disclosed herein. FIG. 32 is an oblique view of a delivery catheter 2004 having the fenestration alignment component 2026 of FIG. 29. FIG. 33 is an exploded view of the delivery catheter 2004 shown in FIG. 32. In some delivery catheter embodiments, one or more fenestration alignment components 2026 can be used in place of or in conjunction with one or more fenestration alignment components 1026 described above in any of the delivery catheter embodiments disclosed herein.

Therefore, the fenestration alignment component 2026 can serve the same or similar function or be used for the same or similar procedural step or steps as with the embodiments of the fenestration alignment component 1026 described above. Therefore, the fenestration alignment component 2026 can be used in any of the procedures, steps, or methods as described above for the fenestration alignment component 1026. For example, after the main body of a prosthesis (such as prosthesis 1010) has been released from the outer sheath 1006 and any other radial restraints, a user can independently or collectively axially advance the fenestration alignment component 2026 relative to the guide sheath 2024 (which can be the same as the guide sheath 1024 described above) supporting the fenestration alignment component 2026 such that a portion of the fenestration alignment component 2026 engages the fenestration or branch graft of the prosthesis 1010 and pushes the fenestration or branch graft toward an ostium of the target branch vessel of the patient's vasculature.

A body portion 2027 of the fenestration alignment component 2026 can be slidably positioned around or over an outside surface of the guide sheath 2024. As illustrated in FIGS. 29, 31, and 32, the body portion 2027 can be cylindrical or tubular. The body portion 2027 can have an inside diameter or size that is greater than an outside diameter or size of the guide sheath 1024 so that the fenestration alignment component 2026 can axially translate relative to the guide sheath 1024. The body portion 2027 can have in inner diameter or cross-sectional size of approximately 0.114 in, or from approximately 0.10 in or less to approximately 0.125 inches or more. The body portion 2027 can have in outer diameter or cross-sectional size of approximately 0.126 in, or from approximately 0.110 in or less to approximately 0.15 inches or more.

The body portion 2027 can have a length of approximately 7.1 cm (2.80 in), or from approximately 5 cm (1.97 in) or less to approximately 10 cm (3.94 in), or between any values within the foregoing range. The body portion 2027 can be formed from a PEBAX covered alloy coil. For example, the body portion 2027 can have a stainless steel coil with a PEBAX tube surrounding the coil. The PEBAX can have varying hardness. The body portion 2027 can have a PTFE liner surrounding all or a portion of the body portion 2027. Additionally, the body portion 2027 can have a radiopaque marker or band supported thereon, or have portions or components thereof that are made from a radiopaque material. For example, a radiopaque band having a length of approximately 0.020 in to approximately 0.060 in can be supported by the body portion 2037.

As will be described in greater detail, the fenestration alignment component 2026 can have a snare, tab, protrusion, or other similar feature supported by the body portion to engage a portion of the prosthesis adjacent to the fenestration. For example, with reference to the illustrated embodiments, the fenestration alignment component 2026 can have a tab or protruding portion 2028 (also referred to as a protrusion or projection) projecting from the body portion 2027. The protruding portion 2028 can project away from the outside surface of the body portion 2027 by approximately 0.036 in, or from approximately 0.025 in to approximately 0.050 in, or from approximately 0.030 in to approximately 0.045 in, or between any values within any of the foregoing ranges. The protruding portion 2028 can define a cross-sectional size (in at least one direction) or diameter that is from approximately 20% or less to approximately 40% or more greater than a cross-sectional size or diameter of the body portion 2027 and/or the fenestration, or between any values within this range.

In some embodiments, the protruding portion or other component or element supported at an end of the body portion 2027 can be inflatable or otherwise moveable between a first position and a second position wherein, in the second position, such component or element projects away from the body portion 2027 more than in the first position. For example, without limitation, the component or element can be a small inflatable balloon positioned at an end of the body portion having a hollow wire in fluid communication with an inner volume thereof. The positioning wire 2030 could be made hollow to allow for inflation of the inflatable component or element.

The protruding portion 2028 can be integrally formed with the body portion 2027, or can be formed separately and adhered to, supported by, or otherwise coupled with the body portion 2027. The protruding portion 2028 can have a length of approximately 7 mm (0.276 in) or from approximately 5 mm (0.197 in) or less to approximately 10 mm (0.394 in) or more, or between any values within the foregoing range. The protruding portion 2028 can be made from PEBAX. The protruding portion 2028 can be made from a PEBAX material having a higher hardness value than the PEBAX material used to form the body portion 2027.

As mentioned, the fenestration alignment component 2026 can be configured to engage a fenestration of a prosthesis deployable by the delivery catheter 2004. For example, the enlarged or protruding portion 2028 can have a size or profile that is greater than a size or profile of the guide sheath 2024 or of the body portion 2027 of the fenestration alignment component 2026 so that, while the guide sheath 2024 can be advanced through the fenestration, the protruding portion 2028 can be sized and configured to be larger than the size or diameter of the fenestration so that the protruding portion 2028 does not pass through the fenestration.

The enlarged portion 2028 of the fenestration alignment component 2026 can have a circular cross-sectional shape or, as illustrated in FIGS. 29-31A, a non-circular cross-sectional shape. For example, the enlarged portion 2028 can have an approximately triangular or pointed shape with a rounded upper surface or portion 2028a. The enlarged portion 2028 can have a circular cross-sectional shape or a pointed shape with more than one pointed or protruding portion, or any other suitable shape.

With reference to FIGS. 29-30, the enlarged portion 2028 can have a tapered surface 2028b at the trailing end of the enlarged portion 2028. The tapered surface 2028b can facilitate the removability of the fenestration alignment component 2026 if the enlarged portion 2028 of the fenestration alignment component 2026 is inadvertently advanced through a fenestration.

The fenestration alignment components 2026 can each be attached to positioning wires 2030 such that axially advancing or retracting the positioning wires 2030 will advance or retract the fenestration alignment components 2026. The positioning wires 2030 can each define a tapering cross-sectional size that decreases toward a distal end of the positioning wire 2030 such that a cross-sectional size of the positioning wire 2030 near the body portion 2027 is smaller than a cross-sectional size of the positioning wire 2030 near the catheter handle. The positioning wire 2030 can made from a PTFE coated stainless steel, such as 304, or from any other suitable material or combination of materials. The positioning wire 2030 can have a diameter or cross-sectional size as large as approximately 0.0345 in, tapering down to a diameter or cross-sectional size of approximately 0.0200 in. The positioning wire 2030 can have a uniform diameter or cross-sectional size along the length thereof.

With reference to FIG. 31B, an end portion 2030a of the positioning wire 2030 can overlap and be affixed to the body portion 2037 of the fenestration alignment component 2026. For example, between approximately 1.0 cm (0.394 in) or less and 1.5 cm (0.591 in) or more of the positioning wire 2030 can overlap the body portion 2037. The end portion 2030a can be bonded to the body portion 2037 using any suitable technique or process. For example, the end portion 2030a can be thermally bonded to the body portion 2037 using one or more PET sleeves. A portion of the end portion 2030a can be coined or flattened. The end portion can have a greater surface area than a remainder of the end portion 2030a. For example, approximately half of the end portion 2030a can be coined or flattened.

FIG. 32 is an oblique view of a delivery catheter 2004 having the fenestration alignment component 2026 of FIG. 29. FIG. 33 is an exploded view of the delivery catheter 2004 shown in FIG. 32. FIG. 32 illustrates a handle portion 2050 of the delivery catheter 2004, which can provide an entry point for the guide sheaths 2024 and the positioning wires 2030 so as to provide an orifice or access port for these components into the main body of the delivery catheter 2004. In this configuration, a surgeon or user can manipulate the guide sheaths 2024 and fenestration alignment components 2026 by manipulating the end portions of the guide sheaths 2024 and positioning wires 2030 that extend proximally from the end of the handle portion 2050 of the delivery catheter.

The catheter 2004 can have two or more guide sheaths 2024 and two or more fenestration alignment components 2026, or the same number of guide sheaths 2024 and fenestration alignment components 2026 as the number of fenestrations in the prosthesis. The catheter 2004 having guide sheaths 2024 with fenestration alignment components 2026 as described herein can be configured such that the guide sheaths 2024, fenestration alignment components 2026, and/or positioning wires 2030 are advanceable within standard lumen formed in the delivery catheter 2004. The lumen of the delivery catheter 2004 may be enlarged or sized and configured to accommodate such guide sheaths 2024 with fenestration alignment components 2026.

FIG. 34 is a sectional view of a portion of a patient's vasculature, showing the fenestration alignment component 2026 illustrated in FIG. 29 advancing an inner wall of the prosthesis adjacent to a fenestration toward an ostium of the target branch vessel. As illustrated, the fenestration alignment component 2026 of the catheter 2004 can be axially advanced relative to the guide sheath 2024 (which can be the same as any other guide sheath embodiments disclosed herein, including without limitation guide sheath 1024) by advancing the positioning wire 2030 distally to push the fenestration 1011 of the prosthesis 1010 over the branch sheath 2024 and into approximate alignment with the ostium of the branch vessel. The catheter system 2004 can be configured to not have a fenestration alignment component 2026, and can accordingly be configured to deploy a fenestrated graft without the use of such a component. As will be described below, snares, protrusions, tabs, or other features can be formed on the sheaths 1024 to push the fenestrations toward the branch vessel ostium.

FIG. 35 is a sectional view of a portion of a patient's vasculature, showing a branch stent being advanced into the target branch vessel while the fenestration alignment component 2026 can be used to maintain the inner wall of the prosthesis adjacent to a fenestration in the prosthesis in the desired position relative to the ostium of the target branch vessel. As illustrated in FIG. 35, the fenestration alignment components 2026 have been advanced to a second position, the second position being defined as the position where the fenestrations 1011 are approximately aligned with the ostium of the target branch vessels. As illustrated in FIG. 35, a covered or uncovered branch stent 1084 can be deployed in the branch vessel by advancing the branch stent 1084 through the branch sheath 2024 using a suitable catheter, such as a renal stent catheter, into the target vessel, after the angiographic catheter has been removed from the branch sheath 2024.

The stent 1084 can be supported on an inflation balloon 1086, which can be supported by a guidewire 1088. The guidewire 1088 can be configured to have an inflation lumen therein, to inflate the balloon 1086 and expand the branch stent 1084 in the target location after the branch sheath 2024 has been at least partially retracted so as to not interfere with the expansion of the branch stent 1084. The fenestration alignment components 2026 may need to be at least partially withdrawn before deploying the stents 1084, to enable the inflation balloon to expand the stents 1084. The inflation balloon 1086 can be configured to expand and flare a portion of the stent 1084 within or to the inside of the fenestration 1011 formed in the prosthesis. Thereafter, the components comprising the delivery catheter 2004 can be withdrawn, and/or additional prostheses can be deployed in the patient's vasculature, including without limitation a suprarenal stent graft, or other desired components.

As mentioned, any embodiments of the delivery catheter 2004 can have any of the same features, materials, components, dimensions, or other details of any other catheter disclosed herein, including without limitation the embodiment(s) of the delivery catheter 1004 described above. Like numbered features shown in the illustrations of the delivery catheter 2004 can be the same or similar to the same numbered features of the delivery catheter 1004 embodiments described herein.

While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the device or process illustrated can be made without departing from the spirit of the disclosure. Additionally, the various features and processes described above can be used independently of one another, or can be combined in various ways. All possible combinations and sub combinations are intended to fall within the scope of this disclosure.

As will be recognized, certain embodiments described herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others. Unless otherwise defined herein, the term approximate or approximately means values within 10% of the stated value.

Additionally, any embodiments of the fenestration alignment components or devices disclosed herein can be used to deploy any suitable fenestrated prosthesis, with or without modification within the scope of one of ordinary skill in the art. For example and any embodiments of the fenestration alignment components or devices disclosed by the references previously incorporated by reference in their entireties as if fully set forth herein. All such embodiments and combinations of embodiments are hereby incorporated by reference as if fully set forth herein. Further, any embodiments of the fenestration alignment components or devices disclosed herein can be used in combination with any of the delivery devices disclosed in either of the foregoing applications, and such combinations are hereby incorporated by reference as if fully set forth herein.

Claims

1. A delivery system comprising: a guide sheath;a fenestrated prosthesis comprising a fenestration;wherein the guide sheath is pre-positioned in a delivery catheter such that, when the delivery catheter and the fenestrated prosthesis are in a predeployment state, the guide sheath is positioned through a lumen of the fenestrated prosthesis and advanced through the fenestration in the fenestrated prosthesis; anda fenestration push device comprising: a body portion defining a lumen therethrough, the lumen having a first radial cross-sectional size, anda protrusion supported at or adjacent to a distal end of the body portion and projecting away from an outside surface of the body portion, the protrusion having a second radial cross-sectional size,wherein the second radial cross-sectional size of the protrusion is greater than the first radial cross-sectional size of the body portion,wherein the protrusion comprises a tapered surface at its trailing end to facilitate removability of the fenestration push device, andwherein the body portion is configured to axially translate over the outside surface of the guide sheath, andwherein the second cross-sectional size of the protrusion is greater than a third cross-sectional size of the fenestration of the fenestrated prosthesis.
2. The delivery system of claim 1, wherein at least a proximal portion of the fenestration push device extends proximally from a handle portion of the delivery catheter toward a user of the device so that the user can advance the fenestration push device toward the fenestration in the fenestrated prosthesis by distally advancing the proximal portion of the fenestration push device.
3. The delivery system of claim 2, wherein the proximal portion of the fenestration push device comprises a wire.
4. The fenestration push device of claim 1, wherein the protrusion is moveable between a first position and a second position wherein, in the second position, the protrusion projects away from the body portion more than in the first position.
5. The fenestration push device of claim 4, wherein the protrusion is an inflatable structure.
6. The fenestration push device of claim 1, wherein the protrusion is not integrally formed with the body portion.
7. The fenestration push device of claim 1, wherein the protrusion has a rounded surface at its distal end.
8. The fenestration push device of claim 7, wherein the protrusion extends along the body portion to the distal end of the body portion.

PRIORITY INFORMATION AND INCORPORATION BY REFERENCE

This application is a divisional of U.S. application Ser. No. 13/287,907, (titled “APPARATUS AND METHOD OF PLACEMENT OF A GRAFT OR GRAFT SYSTEM”), filed Nov. 2, 2011, which claims priority benefit of U.S. Provisional Application No. 61/409,504 (titled “APPARATUS AND METHOD OF PLACEMENT OF A GRAFT OR GRAFT SYSTEM”), filed Nov. 2, 2010, which application is hereby incorporated by reference in its entirety as if fully set forth herein. The benefit of priority is claimed under the appropriate legal basis including, without limitation, under 35 U.S.C. § 119(e). Additionally, U.S. patent application Ser. No. 12/769,506, filed on Apr. 28, 2010 (entitled “APPARATUS AND METHOD OF PLACEMENT OF A GRAFT OR GRAFT SYSTEM”) is also hereby incorporated by reference in its entirety as if fully set forth herein.

US Referenced Citations (821)

Number	Name	Date	Kind
2127903	Bowen	Aug 1938	A
2437542	Krippendorf	May 1944	A
2845959	Sidebotham	Aug 1958	A
2990605	Demsyk	Jul 1961	A
3029819	Starks	Apr 1962	A
3096560	Liebig	Jul 1963	A
3805301	Liebig	Apr 1974	A
3994149	Dahlman	Nov 1976	A
4362156	Feller, Jr. et al.	Dec 1982	A
4473067	Schiff	Sep 1984	A
4497074	Ray et al.	Feb 1985	A
4501263	Harbuck	Feb 1985	A
4503568	Madras	Mar 1985	A
4512338	Balko et al.	Apr 1985	A
4525157	Vaillancourt	Jun 1985	A
4562596	Kornberg	Jan 1986	A
4580568	Gianturco	Apr 1986	A
4592754	Gupte et al.	Jun 1986	A
4617932	Kornberg	Oct 1986	A
4756307	Crownshield	Jul 1988	A
4795465	Marten	Jan 1989	A
4800882	Gianturco	Jan 1989	A
4816028	Kapadia et al.	Mar 1989	A
4840940	Sottiurai	Jun 1989	A
4856516	Hillstead	Aug 1989	A
4878906	Lindemann et al.	Nov 1989	A
4907336	Gianturco	Mar 1990	A
4922905	Strecker	May 1990	A
4981478	Evard et al.	Jan 1991	A
4981947	Tomagou et al.	Jan 1991	A
4994069	Ritchrt et al.	Feb 1991	A
4994071	MacGregor	Feb 1991	A
5019090	Pinchuk	May 1991	A
5035706	Giantureo et al.	Jul 1991	A
5064435	Porter	Nov 1991	A
5071425	Gifford, III	Dec 1991	A
5078726	Kreamer	Jan 1992	A
5100424	Jang	Mar 1992	A
5104399	Lazarus	Apr 1992	A
5108424	Hoffman, Jr. et al.	Apr 1992	A
5116349	Aranyi	May 1992	A
5123917	Lee	Jun 1992	A
5133732	Wiktor	Jul 1992	A
5135535	Kramer	Aug 1992	A
5135536	Hillstead	Aug 1992	A
5151105	Kwan-Gett	Sep 1992	A
5156619	Ehrenfeld	Oct 1992	A
5158545	Trudell et al.	Oct 1992	A
5178634	Martinez	Jan 1993	A
5197976	Herweck et al.	Mar 1993	A
5201757	Heyn et al.	Apr 1993	A
5211658	Clouse	May 1993	A
5246452	Sinnott	Sep 1993	A
5256141	Gancheff et al.	Oct 1993	A
5275622	Lazarus et al.	Jan 1994	A
5282860	Matsuno et al.	Jan 1994	A
5282478	Fleischhaker et al.	Feb 1994	A
5282824	Giantureo	Feb 1994	A
5304200	Spaulding	Apr 1994	A
5314444	Giantureo	May 1994	A
5314472	Fontaine	May 1994	A
5316023	Palmaz et al.	May 1994	A
5320602	Karpeil	Jun 1994	A
5330500	Song	Jul 1994	A
5342387	Summers	Aug 1994	A
5354308	Simon et al.	Oct 1994	A
5360443	Barone et al.	Nov 1994	A
5366504	Andersen et al.	Nov 1994	A
5370683	Fontaine	Dec 1994	A
5387235	Chuter	Feb 1995	A
5397355	Marin et al.	Mar 1995	A
5403341	Solar	Apr 1995	A
5405377	Cragg	Apr 1995	A
5405378	Strecker	Apr 1995	A
5414664	Lin et al.	May 1995	A
5415178	Hsi et al.	May 1995	A
5415664	Pinchuk	May 1995	A
5423886	Arru et al.	Jun 1995	A
5425765	Tiefenbrun et al.	Jun 1995	A
5443477	Marin et al.	Aug 1995	A
5443498	Fontaine	Aug 1995	A
5443500	Sigwart	Aug 1995	A
5453090	Martinez et al.	Sep 1995	A
5458615	Klemm et al.	Oct 1995	A
5462530	Jang	Oct 1995	A
5464449	Ryan et al.	Nov 1995	A
5464450	Buscemi et al.	Nov 1995	A
5484444	Braunschweiler et al.	Jan 1996	A
5489295	Piplani et al.	Feb 1996	A
5496365	Sgro	Mar 1996	A
5507767	Maeda et al.	Apr 1996	A
5507768	Lau et al.	Apr 1996	A
5507769	Marin et al.	Apr 1996	A
5507771	Gianturco	Apr 1996	A
5522880	Barone et al.	Jun 1996	A
5522881	Lentz	Jun 1996	A
5522883	Slater et al.	Jun 1996	A
5523092	Slater et al.	Jun 1996	A
5545211	An et al.	Aug 1996	A
5549635	Solar	Aug 1996	A
5545118	Jang	Sep 1996	A
5554181	Das	Sep 1996	A
5562697	Christiansen	Oct 1996	A
5562724	Vorwerk et al.	Oct 1996	A
5562726	Chuter	Oct 1996	A
5562728	Lazarus et al.	Oct 1996	A
5571169	Plaia et al.	Nov 1996	A
5571172	Chin	Nov 1996	A
5571173	Parodi	Nov 1996	A
5575816	Rudnick et al.	Nov 1996	A
5575818	Pinchuk	Nov 1996	A
5578071	Parodi	Nov 1996	A
5578072	Barone et al.	Nov 1996	A
5591195	Taheri et al.	Jan 1997	A
5591197	Orth et al.	Jan 1997	A
5591198	Boyle et al.	Jan 1997	A
5591226	Trerotola et al.	Jan 1997	A
5591229	Parodi	Jan 1997	A
5591230	Horn et al.	Jan 1997	A
5593417	Rhodes	Jan 1997	A
5604435	Foo et al.	Feb 1997	A
5607445	Summers	Mar 1997	A
5609625	Piplani et al.	Mar 1997	A
5609627	Goicoechea et al.	Mar 1997	A
5609628	Keranen	Mar 1997	A
5628783	Quiachon et al.	May 1997	A
5628786	Banas et al.	May 1997	A
5628788	Pinchuk	May 1997	A
5630829	Lauterjung	May 1997	A
5630830	Verbeek	May 1997	A
5632763	Glastra	May 1997	A
5632772	Alcime et al.	May 1997	A
5639278	Dereume et al.	Jun 1997	A
5641373	Shannon et al.	Jun 1997	A
5643171	Bradshaw et al.	Jul 1997	A
5643278	Wijay	Jul 1997	A
5643339	Kavteladze et al.	Jul 1997	A
5647857	Anderson et al.	Jul 1997	A
5649952	Lam	Jul 1997	A
5651174	Schwartz et al.	Jul 1997	A
5653727	Wiktor	Aug 1997	A
5653743	Martin	Aug 1997	A
5653746	Schmitt	Aug 1997	A
5653747	Dereume	Aug 1997	A
5662580	Bradshaw et al.	Sep 1997	A
5662614	Edoga	Sep 1997	A
5662675	Polanskyj Stockert et al.	Sep 1997	A
5662700	Lazarus	Sep 1997	A
5662701	Plaia et al.	Sep 1997	A
5662702	Keranen	Sep 1997	A
5662703	Yurek et al.	Sep 1997	A
5665115	Cragg	Sep 1997	A
5665117	Rhodes	Sep 1997	A
5666968	Imran et al.	Sep 1997	A
5669880	Solar	Sep 1997	A
5669924	Shaknovich	Sep 1997	A
5669934	Sawyer	Sep 1997	A
5674241	Bley et al.	Oct 1997	A
5674276	Andersen et al.	Oct 1997	A
5676685	Razaivi	Oct 1997	A
5676696	Marcade	Oct 1997	A
5676697	McDonald	Oct 1997	A
5679400	Tuch	Oct 1997	A
5681345	Tuteneuer	Oct 1997	A
5681346	Orth et al.	Oct 1997	A
5683448	Cragg	Nov 1997	A
5683449	Marcade	Nov 1997	A
5683450	Goicoechea et al.	Nov 1997	A
5683451	Lenker et al.	Nov 1997	A
5683452	Barone et al.	Nov 1997	A
5683453	Palmaz	Nov 1997	A
5690642	Osborne et al.	Nov 1997	A
5690643	Wijay	Nov 1997	A
5690644	Yurek et al.	Nov 1997	A
5690671	McGurk et al.	Nov 1997	A
5693066	Rupp et al.	Dec 1997	A
5693084	Chuter	Dec 1997	A
5693086	Goicoechea et al.	Dec 1997	A
5693087	Parodi	Dec 1997	A
5693088	Lazarus	Dec 1997	A
5695516	Fischell et al.	Dec 1997	A
5695517	Marin et al.	Dec 1997	A
5697948	Marin et al.	Dec 1997	A
5697971	Fischell et al.	Dec 1997	A
5709703	Lukic et al.	Jan 1998	A
5713917	Leonhardt	Feb 1998	A
5716365	Goicoechea et al.	Feb 1998	A
5716393	Lindenberg et al.	Feb 1998	A
5718724	Goicoechea et al.	Feb 1998	A
5718973	Lewis et al.	Feb 1998	A
5720735	Dorros	Feb 1998	A
5720776	Chuter et al.	Feb 1998	A
5723004	Dereume et al.	Mar 1998	A
5733325	Robinson et al.	Mar 1998	A
5746776	Smith et al.	May 1998	A
5749880	Banas et al.	May 1998	A
5755735	Richter et al.	May 1998	A
5755770	Ravenscroft	May 1998	A
5755771	Penn et al.	May 1998	A
5755777	Chuter	May 1998	A
5765682	Bley et al.	Jun 1998	A
5766203	Imran et al.	Jun 1998	A
5769885	Quiachon et al.	Jun 1998	A
5769887	Brown et al.	Jun 1998	A
5782855	Lau et al.	Jul 1998	A
5782909	Quiachon et al.	Jul 1998	A
5800456	Maeda et al.	Sep 1998	A
5800508	Goicoechea et al.	Sep 1998	A
5800526	Anderson et al.	Sep 1998	A
5810836	Hussein et al.	Sep 1998	A
5817100	Igaki	Oct 1998	A
5823198	Jones et al.	Oct 1998	A
5824037	Fogarty et al.	Oct 1998	A
5824039	Piplani et al.	Oct 1998	A
5824040	Cox et al.	Oct 1998	A
5824053	Khosravi et al.	Oct 1998	A
5843160	Rhodes	Dec 1998	A
5843162	Inoue	Dec 1998	A
5843164	Frantzen et al.	Dec 1998	A
5843167	Dwyer et al.	Dec 1998	A
5851228	Pinheiro	Dec 1998	A
5855599	Wan	Jan 1999	A
5855600	Alt	Jan 1999	A
5860998	Robinson et al.	Jan 1999	A
5867432	Toda	Feb 1999	A
5868783	Tower	Feb 1999	A
5871536	Lazarus	Feb 1999	A
5873906	Lau et al.	Feb 1999	A
5879321	Hill	Mar 1999	A
5879366	Shaw et al.	Mar 1999	A
5891193	Robinson et al.	Apr 1999	A
5893868	Hanson et al.	Apr 1999	A
5893887	Jayaraman	Apr 1999	A
5902334	Dwyer et al.	May 1999	A
5906640	Penn et al.	May 1999	A
5906641	Thompson et al.	May 1999	A
5916263	Goicoceha et al.	Jun 1999	A
5919225	Lau et al.	Jul 1999	A
5925075	Myers et al.	Jul 1999	A
5928248	Acker	Jul 1999	A
5928279	Shannon et al.	Jul 1999	A
5935161	Robinson et al.	Aug 1999	A
5938696	Goicoechea et al.	Aug 1999	A
5948017	Taheri	Sep 1999	A
5948018	Dereume et al.	Sep 1999	A
5957929	Brenneman	Sep 1999	A
5957973	Quiachon et al.	Sep 1999	A
5961546	Robinson et al.	Oct 1999	A
5961548	Shmulewitz	Oct 1999	A
5980514	Kupiecki et al.	Nov 1999	A
5984929	Bashiri et al.	Nov 1999	A
5984955	Wisselink	Nov 1999	A
5989242	Saadat et al.	Nov 1999	A
5993489	Lewis et al.	Nov 1999	A
6001125	Golds et al.	Dec 1999	A
6004347	McNamara et al.	Dec 1999	A
6004348	Banas et al.	Dec 1999	A
6017363	Hojeibane	Jan 2000	A
6027508	Ren et al.	Feb 2000	A
6027520	Tsugita et al.	Feb 2000	A
6027779	Campbell et al.	Feb 2000	A
6027811	Campbell et al.	Feb 2000	A
6030415	Chuter	Feb 2000	A
6033434	Borghi	Mar 2000	A
6039749	Marin et al.	Mar 2000	A
6039755	Edwin et al.	Mar 2000	A
6039758	Quiachon et al.	Mar 2000	A
6045557	White et al.	Apr 2000	A
6051020	Goicoechea et al.	Apr 2000	A
6053940	Wijay	Apr 2000	A
6056722	Jayaraman	May 2000	A
6059813	Vrba et al.	May 2000	A
6059824	Taheri	May 2000	A
6063092	Shin	May 2000	A
6063113	Kavteladze et al.	May 2000	A
6068654	Berg et al.	May 2000	A
6070589	Keith et al.	Jun 2000	A
6074398	Leschinsky	Jun 2000	A
6077296	Shokoohi et al.	Jun 2000	A
6077297	Robinson et al.	Jun 2000	A
6086611	Duffy et al.	Jul 2000	A
6090128	Douglas	Jul 2000	A
6090135	Plaia et al.	Jul 2000	A
6093194	Mikus et al.	Jul 2000	A
6093203	Uflacker	Jul 2000	A
6096027	Layne	Aug 2000	A
6106548	Reubin et al.	Aug 2000	A
6117167	Goicoechea et al.	Sep 2000	A
6123722	Fogarty et al.	Sep 2000	A
6123723	Konya et al.	Sep 2000	A
6126685	Lenker et al.	Oct 2000	A
6129756	Kugler et al.	Oct 2000	A
6136006	Johnson et al.	Oct 2000	A
6143002	Vietmeier	Nov 2000	A
6143016	Bleam et al.	Nov 2000	A
6146389	Geitz	Nov 2000	A
6146415	Fitz	Nov 2000	A
6149681	Houser et al.	Nov 2000	A
6152944	Holman et al.	Nov 2000	A
6156063	Douglas	Dec 2000	A
6162237	Chan	Dec 2000	A
6165195	Wilson et al.	Dec 2000	A
6165214	Lazarus	Dec 2000	A
6168610	Marin et al.	Jan 2001	B1
6171281	Zhang	Jan 2001	B1
6183481	Lee et al.	Feb 2001	B1
6183509	Dibie	Feb 2001	B1
6187015	Brenneman	Feb 2001	B1
6187033	Schmitt et al.	Feb 2001	B1
6187036	Shaolian et al.	Feb 2001	B1
6192944	Greenhalgh	Feb 2001	B1
6193726	Vanney	Feb 2001	B1
6193745	Fogarty et al.	Feb 2001	B1
6197049	Shaolian et al.	Mar 2001	B1
6203735	Edwin et al.	Mar 2001	B1
6210429	Vardi et al.	Apr 2001	B1
6221090	Wilson	Apr 2001	B1
6221098	Wilson	Apr 2001	B1
6221102	Baker et al.	Apr 2001	B1
6224609	Ressemann et al.	May 2001	B1
6224627	Armstrong et al.	May 2001	B1
6231563	White et al.	May 2001	B1
6235051	Murphy	May 2001	B1
6254609	Vrba et al.	Jul 2001	B1
6254628	Wallace et al.	Jul 2001	B1
6261316	Shaolian et al.	Jul 2001	B1
6264682	Wilson et al.	Jul 2001	B1
6273909	Kugler et al.	Aug 2001	B1
6280465	Cryer	Aug 2001	B1
6280466	Kugler et al.	Aug 2001	B1
6280467	Leonhardt	Aug 2001	B1
6283991	Cox et al.	Sep 2001	B1
6287329	Duering et al.	Sep 2001	B1
6296622	Kurz et al.	Oct 2001	B1
6312406	Jayaiaman	Nov 2001	B1
6325826	Vardi et al.	Dec 2001	B1
6331184	Abrams	Dec 2001	B1
6331190	Shokoohi et al.	Dec 2001	B1
6334867	Anson	Jan 2002	B1
6344056	Dehdashtian	Feb 2002	B1
6346118	Baker et al.	Feb 2002	B1
6348066	Pinchuk et al.	Feb 2002	B1
6350278	Lenker et al.	Feb 2002	B1
6352553	Van der Burg et al.	Mar 2002	B1
6352554	De Paulis	Mar 2002	B2
6352561	Leopold et al.	Mar 2002	B1
6355060	Lenker et al.	Mar 2002	B1
6361544	Wilson et al.	Mar 2002	B1
6361555	Wilson	Mar 2002	B1
6361557	Gittings et al.	Mar 2002	B1
6361559	Houser et al.	Mar 2002	B1
6361637	Martin et al.	Mar 2002	B2
6383213	Wilson et al.	May 2002	B2
6387120	Wilson et al.	May 2002	B2
6395017	Dwyer et al.	May 2002	B1
6395018	Castaneda	May 2002	B1
6395019	Chobotov	May 2002	B2
6398807	Chouinard et al.	Jun 2002	B1
6409750	Hyodoh et al.	Jun 2002	B1
6409757	Trout, III et al.	Jun 2002	B1
6416474	Penner et al.	Jul 2002	B1
6416542	Marcade et al.	Jul 2002	B1
6425765	Irwin, III	Jul 2002	B1
6428565	Wisselink	Aug 2002	B1
6428567	Wilson et al.	Aug 2002	B2
6432131	Ravenscroft	Aug 2002	B1
6432134	Anson et al.	Aug 2002	B1
6436135	Goldfarb	Aug 2002	B1
6440161	Madrid et al.	Aug 2002	B1
6447540	Fontaine et al.	Sep 2002	B1
6482211	Choi	Sep 2002	B1
6458152	Khosravi et al.	Oct 2002	B1
6464721	Marcade et al.	Oct 2002	B1
6432130	Hanson	Nov 2002	B1
6475166	Escano	Nov 2002	B1
6475170	Doron et al.	Nov 2002	B1
6485513	Fan	Nov 2002	B1
6491719	Fogrty et al.	Dec 2002	B1
6500182	Foster	Dec 2002	B2
6500202	Shaolian et al.	Dec 2002	B1
6508833	Pavcnick et al.	Jan 2003	B2
6508835	Shaolian et al.	Jan 2003	B1
6508836	Wilson et al.	Jan 2003	B2
6511325	Lalka et al.	Jan 2003	B1
6514281	Blaeser et al.	Feb 2003	B1
6514282	Inoue	Feb 2003	B1
6517572	Kugler et al.	Feb 2003	B2
6517573	Pollock et al.	Feb 2003	B1
6520988	Colombo et al.	Feb 2003	B1
6524335	Hartley et al.	Feb 2003	B1
6524336	Papazolgou et al.	Feb 2003	B1
6533811	Ryan et al.	Mar 2003	B1
6544278	Vrba et al.	Apr 2003	B1
6551350	Thornton et al.	Apr 2003	B1
6558396	Inoue	May 2003	B1
6562063	Euteneurer et al.	May 2003	B1
6565596	White et al.	May 2003	B1
6565597	Fearnot et al.	May 2003	B1
RE38146	Palmaz et al.	Jun 2003	E
6572645	Leonhardt	Jun 2003	B2
6576005	Geitz	Jun 2003	B1
6576009	Ryan et al.	Jun 2003	B2
6579308	Jansen et al.	Jun 2003	B1
6579312	Wilson et al.	Jun 2003	B2
6582394	Reiss et al.	Jun 2003	B1
6582460	Cryer	Jun 2003	B1
6585758	Chouinard et al.	Jul 2003	B1
6592548	Jayaraman	Jul 2003	B2
6592614	Lenker et al.	Jul 2003	B2
6592615	Marcade et al.	Jul 2003	B1
6599315	Wilson	Jul 2003	B2
6607552	Hanson	Aug 2003	B1
6613073	White et al.	Sep 2003	B1
6616675	Evard et al.	Sep 2003	B1
6645242	Quinn	Nov 2003	B1
6652567	Deaton	Nov 2003	B1
6652579	Cox et al.	Nov 2003	B1
6656213	Solem	Dec 2003	B2
6660033	Marcade et al.	Dec 2003	B1
6663665	Shaolian et al.	Dec 2003	B2
6669718	Besselink	Dec 2003	B2
6692483	Vardi et al.	Feb 2004	B2
6695875	Stelter et al.	Feb 2004	B2
6706062	Vardi et al.	Mar 2004	B2
6723116	Taheri	Apr 2004	B2
6702843	Brown et al.	May 2004	B1
6733523	Shaolian et al.	May 2004	B2
6740101	Houser et al.	May 2004	B2
6761733	Chobotov et al.	Jul 2004	B2
6767359	Weadock	Jul 2004	B2
6773457	Ivancev et al.	Aug 2004	B2
6790224	Gerberding	Sep 2004	B2
6793671	Wall	Sep 2004	B2
6800065	Duane et al.	Oct 2004	B2
6802859	Pazienza et al.	Oct 2004	B1
6811566	Penn et al.	Nov 2004	B1
6814752	Chuter	Nov 2004	B1
6818014	Brown et al.	Nov 2004	B2
6821292	Pazienza et al.	Nov 2004	B2
6827706	Parodi	Dec 2004	B2
6827726	Parodi	Dec 2004	B2
6833003	Jones et al.	Dec 2004	B2
6835203	Vardi et al.	Dec 2004	B1
6840950	Standford et al.	Jan 2005	B2
6858038	Heuser	Feb 2005	B2
6875229	Wilson et al.	Apr 2005	B2
6887249	Houser et al.	May 2005	B1
6887251	Suval	May 2005	B1
6889026	Schlageter et al.	May 2005	B2
6896699	Wilson et al.	May 2005	B2
6899727	Armstrong et al.	May 2005	B2
6899728	Phillips et al.	May 2005	B1
6905505	Nash et al.	Jun 2005	B2
6908477	McGuckin	Jun 2005	B2
6918925	Tehrani	Jul 2005	B2
6923829	Boyle et al.	Aug 2005	B2
6929661	Bolduc et al.	Aug 2005	B2
6932837	Amplatz et al.	Aug 2005	B2
6939368	Simso	Sep 2005	B2
6939371	Kugler et al.	Sep 2005	B2
6939377	Jayaraman et al.	Sep 2005	B2
6942691	Chuter	Sep 2005	B1
6942692	Landau et al.	Sep 2005	B2
6942693	Chouinard et al.	Sep 2005	B2
6948017	Carpenter et al.	Sep 2005	B2
6953475	Shaolian et al.	Oct 2005	B2
6955679	Hendricksen et al.	Oct 2005	B1
6955688	Wilson et al.	Oct 2005	B2
6960217	Bolduc	Nov 2005	B2
6962602	Vardi	Nov 2005	B2
6974471	Van Schie et al.	Dec 2005	B2
6981982	Armstrong et al.	Jan 2006	B2
6984244	Perez et al.	Jan 2006	B2
6989024	Hebert et al.	Jan 2006	B2
6989026	Richter et al.	Jan 2006	B2
6994721	Israel	Feb 2006	B2
6994722	DiCarlo	Feb 2006	B2
7004926	Navia et al.	Feb 2006	B2
7004964	Thompson et al.	Feb 2006	B2
7004967	Chouinard et al.	Feb 2006	B2
7014653	Ouriel et al.	Mar 2006	B2
7025779	Elliott	Apr 2006	B2
7029494	Soun et al.	Apr 2006	B2
7029496	Rakos et al.	Apr 2006	B2
7074235	Roy	Jul 2006	B1
7074236	Rabkin et al.	Jul 2006	B2
7105015	Goshgarian	Sep 2006	B2
7105017	Kerr	Sep 2006	B2
7105020	Greenberg et al.	Sep 2006	B2
7118593	Davidson et al.	Oct 2006	B2
7122051	Dallara et al.	Oct 2006	B1
7122052	Greenhalgh	Oct 2006	B2
7125464	Chobotov et al.	Oct 2006	B2
7131991	Zarins et al.	Nov 2006	B2
7144422	Rao	Dec 2006	B1
7160318	Greenberg et al.	Jan 2007	B2
7162302	Wang et al.	Jan 2007	B2
7163715	Kramer	Jan 2007	B1
7175651	Kerr	Feb 2007	B2
7175652	Cook et al.	Feb 2007	B2
7175657	Khan et al.	Feb 2007	B2
7189256	Smith	Mar 2007	B2
7189257	Schmitt et al.	Mar 2007	B2
7195648	Jones et al.	Mar 2007	B2
7201770	Johnson et al.	Apr 2007	B2
7220274	Quinn	May 2007	B1
7220275	Davidson et al.	May 2007	B2
7229472	DePalma et al.	Jun 2007	B2
7232449	Sharkawy et al.	Jun 2007	B2
7235095	Haverkost et al.	Jun 2007	B2
7237552	Khera et al.	Jul 2007	B2
7241300	Sharkawy et al.	Jul 2007	B2
7244444	Bates	Jul 2007	B2
7261733	Brown et al.	Aug 2007	B1
7264631	DeCarlo	Sep 2007	B2
7264632	Wright et al.	Sep 2007	B2
7267685	Butaric et al.	Sep 2007	B2
7270675	Chun et al.	Sep 2007	B2
7285130	Austin	Oct 2007	B2
7294145	Ward	Nov 2007	B2
7300460	Levine et al.	Nov 2007	B2
7306623	Watson	Dec 2007	B2
7309351	Escamilla et al.	Dec 2007	B2
7314481	Karpiel	Jan 2008	B2
7314483	Landau et al.	Jan 2008	B2
7320703	DiMatteo et al.	Jan 2008	B2
7341598	Davidson et al.	Mar 2008	B2
7367985	Mazzocchi et al.	May 2008	B2
7367986	Mazzocchi et al.	May 2008	B2
7371250	Mazzocchi et al.	May 2008	B2
7402168	Acosta et al.	Jul 2008	B2
7402171	Osborne et al.	Jul 2008	B2
7413573	Hartley et al.	Aug 2008	B2
7425219	Quadri et al.	Sep 2008	B2
7435253	Hartley et al.	Oct 2008	B1
7438721	Doig et al.	Oct 2008	B2
7491230	Holman et al.	Feb 2009	B2
7491232	Bolduc et al.	Feb 2009	B2
7520890	Phillips	Apr 2009	B2
7520895	Douglas et al.	Apr 2009	B2
7527636	Dunfee et al.	May 2009	B2
7537606	Hartley	May 2009	B2
7553324	Andreas et al.	Jun 2009	B2
7572289	Sisken et al.	Aug 2009	B2
7575590	Watson	Aug 2009	B2
7578841	Yadin et al.	Aug 2009	B2
7582111	Krolik et al.	Sep 2009	B2
7591832	Eversull et al.	Sep 2009	B2
7591843	Escano et al.	Sep 2009	B1
7611529	Greenberg et al.	Nov 2009	B2
7615072	Rust et al.	Nov 2009	B2
7618398	Holman et al.	Nov 2009	B2
7632299	Weber	Dec 2009	B2
7635383	Gumm	Dec 2009	B2
7637932	Bolduc et al.	Dec 2009	B2
7641684	Hilaire et al.	Jan 2010	B2
7645298	Hartley et al.	Jan 2010	B2
7651519	Dittman	Jan 2010	B2
7670369	Shaeffer et al.	Mar 2010	B2
7674284	Melsheimer	Mar 2010	B2
7678141	Greenan et al.	Mar 2010	B2
7691135	Shaolian et al.	Apr 2010	B2
7695508	Van Der Leest et al.	Apr 2010	B2
7699885	Leonhardt et al.	Apr 2010	B2
7708771	Chuter et al.	May 2010	B2
7708773	Pinchuk et al.	May 2010	B2
7722657	Hartley	May 2010	B2
7753951	Shaked et al.	Jul 2010	B2
7758633	Nazzaro	Jul 2010	B2
7766961	Patel et al.	Aug 2010	B2
7771465	Zukowski	Aug 2010	B2
7785340	Heidner et al.	Aug 2010	B2
7785361	Nikolchev et al.	Aug 2010	B2
7806917	Xiao	Oct 2010	B2
7815601	Jordan et al.	Oct 2010	B2
7815661	Mirizzi et al.	Oct 2010	B2
7828837	Khoury	Nov 2010	B2
7833259	Boatman	Nov 2010	B2
7867270	Hartley	Jan 2011	B2
7879081	DeMatteo et al.	Feb 2011	B2
7892275	Hartley et al.	Feb 2011	B2
7909873	Tan-Malecki et al.	Mar 2011	B2
7914572	Hartley et al.	Mar 2011	B2
8034100	Shaolian et al.	Oct 2011	B2
8100960	Bruszewski	Jan 2012	B2
8118856	Schreck et al.	Feb 2012	B2
8152830	Gumm	Apr 2012	B2
8206430	Mafi	Jun 2012	B2
8216295	Bemjamin et al.	Jul 2012	B2
8221494	Schreck et al.	Jul 2012	B2
8236040	Mayberry et al.	Aug 2012	B2
8343204	Osborne	Jan 2013	B2
8357192	Mayberry et al.	Jan 2013	B2
8491646	Schreck	Jul 2013	B2
8523931	Mayberry et al.	Sep 2013	B2
8672989	Schreck et al.	Mar 2014	B2
8764812	Mayberry et al.	Jul 2014	B2
8808350	Schreck et al.	Aug 2014	B2
8828074	Xiao et al.	Sep 2014	B2
8845708	Hartley et al.	Sep 2014	B2
8945202	Mayberry et al.	Feb 2015	B2
9149381	Schreck et al.	Oct 2015	B2
20010003161	Vardi	Jun 2001	A1
20010014823	Ressemann	Aug 2001	A1
20010016767	Wilson et al.	Aug 2001	A1
20010027338	Greenberg	Oct 2001	A1
20010037142	Stelter et al.	Nov 2001	A1
20010039445	Hall et al.	Nov 2001	A1
20020042650	Vardi et al.	Apr 2002	A1
20020049412	Madrid et al.	Apr 2002	A1
20020052648	McGuckin et al.	May 2002	A1
20020116047	Vardi	Aug 2002	A1
20020123786	Gittings et al.	Sep 2002	A1
20020138088	Nash et al.	Sep 2002	A1
20020143383	Parodi	Oct 2002	A1
20020147491	Khan et al.	Oct 2002	A1
20020156516	Vardi	Oct 2002	A1
20020156518	Tehrani	Oct 2002	A1
20020173835	Bourang et al.	Nov 2002	A1
20020193872	Trout et al.	Dec 2002	A1
20020198585	Wisselink	Dec 2002	A1
20030004560	Chobotov et al.	Jan 2003	A1
20030028233	Vardi et al.	Feb 2003	A1
20030083678	Herweck et al.	May 2003	A1
20030097169	Brucker et al.	May 2003	A1
20030135257	Taheri	Jul 2003	A1
20030167083	Lashinski et al.	Sep 2003	A1
20030176910	Vrba et al.	Sep 2003	A1
20030199967	Hartley	Oct 2003	A1
20030236565	DiMatteo et al.	Dec 2003	A1
20030236566	Heuser	Dec 2003	A1
20040015231	Suhr	Jan 2004	A1
20040049204	Harari et al.	Mar 2004	A1
20040049257	Kaspersen et al.	Mar 2004	A1
20040059406	Cully	Mar 2004	A1
20040073288	Kerr	Apr 2004	A1
20040093058	Cottone et al.	May 2004	A1
20040098084	Hartley et al.	May 2004	A1
20040098096	Eton	May 2004	A1
20040106972	Deaton	Jun 2004	A1
20040127975	Levine et al.	Jul 2004	A1
20040143312	Samson et al.	Jul 2004	A1
20040176832	Hartley et al.	Sep 2004	A1
20040193254	Greenberg et al.	Sep 2004	A1
20040215327	Doig et al.	Oct 2004	A1
20040230287	Hartley et al.	Nov 2004	A1
20040236403	Leonhardt et al.	Nov 2004	A1
20050015135	Shanley	Jan 2005	A1
20050033403	Ward et al.	Feb 2005	A1
20050033405	Solovay	Feb 2005	A1
20050038494	Eidenschink	Feb 2005	A1
20050049672	Murphy	Mar 2005	A1
20050058327	Pieper	Mar 2005	A1
20050059923	Gamboa	Mar 2005	A1
20050059994	Walak et al.	Mar 2005	A1
20050060025	Mackiewicz et al.	Mar 2005	A1
20050060026	Gamboa	Mar 2005	A1
20050080476	Gunderson et al.	Apr 2005	A1
20050085845	Hilaire et al.	Apr 2005	A1
20050085891	Goto et al.	Apr 2005	A1
20050102018	Carpenter et al.	May 2005	A1
20050113693	Smith et al.	May 2005	A1
20050113853	Noriega et al.	May 2005	A1
20050113905	Greenberg et al.	May 2005	A1
20050119719	Wallace et al.	Jun 2005	A1
20050119731	Brucker et al.	Jun 2005	A1
20050121120	Van Dijk et al.	Jun 2005	A1
20050131517	Hartley et al.	Jun 2005	A1
20050131518	Hartley et al.	Jun 2005	A1
20050131519	Hartley	Jun 2005	A1
20050131526	Wong	Jun 2005	A1
20050149166	Schaeffer et al.	Jul 2005	A1
20050154444	Quadri	Jul 2005	A1
20050159758	Laks	Jul 2005	A1
20050159803	Lad et al.	Jul 2005	A1
20050165470	Weber	Jul 2005	A1
20050165480	Jordan et al.	Jul 2005	A1
20050171597	Boatman et al.	Aug 2005	A1
20050171598	Schaeffer	Aug 2005	A1
20050177221	Mustapha	Aug 2005	A1
20050215327	Weisel et al.	Sep 2005	A1
20050216043	Blatter et al.	Sep 2005	A1
20050222668	Schaeffer et al.	Oct 2005	A1
20050228480	Douglas et al.	Oct 2005	A1
20050240153	Opie	Oct 2005	A1
20050240258	Bolduc et al.	Oct 2005	A1
20050240260	Bolduc	Oct 2005	A1
20050273150	Howel et al.	Dec 2005	A1
20050288772	Douglas et al.	Dec 2005	A1
20060020320	Shaolian et al.	Jan 2006	A1
20060036315	Yadin et al.	Feb 2006	A1
20060058864	Schaeffer et al.	Mar 2006	A1
20060089704	Douglas	Apr 2006	A1
20060142704	Lentz	Jun 2006	A1
20060142838	Molaei et al.	Jun 2006	A1
20060149350	Patel et al.	Jul 2006	A1
20060155358	LaDuca et al.	Jul 2006	A1
20060155363	LaDuca et al.	Jul 2006	A1
20060155366	LaDuca et al.	Jul 2006	A1
20060161244	Sequin	Jul 2006	A1
20060173525	Behl et al.	Aug 2006	A1
20060178726	Myles	Aug 2006	A1
20060217794	Ruiz et al.	Sep 2006	A1
20060224232	Chobotov	Oct 2006	A1
20060229669	Mirizzi et al.	Oct 2006	A1
20060229699	Tehran et al.	Oct 2006	A1
20060229707	Khoury	Oct 2006	A1
20060233990	Humphrey et al.	Oct 2006	A1
20060233991	Humphrey et al.	Oct 2006	A1
20060247760	Ganesan et al.	Nov 2006	A1
20060247761	Greenberg et al.	Nov 2006	A1
20060259063	Bates et al.	Nov 2006	A1
20060271163	Shokoohi	Nov 2006	A1
20060271164	Shaolian et al.	Nov 2006	A1
20070010867	Carter et al.	Jan 2007	A1
20070016280	Yacoby et al.	Jan 2007	A1
20070021828	Krolik et al.	Jan 2007	A1
20070027522	Chang et al.	Feb 2007	A1
20070027526	Demetriades et al.	Feb 2007	A1
20070043425	Hartley et al.	Feb 2007	A1
20070050016	Gregorich et al.	Mar 2007	A1
20070055350	Erickson	Mar 2007	A1
20070055360	Hanson et al.	Mar 2007	A1
20070055362	Brown	Mar 2007	A1
20070067019	Miller et al.	Mar 2007	A1
20070067023	Kveen et al.	Mar 2007	A1
20070073376	Krolik et al.	Mar 2007	A1
20070073388	Krolik et al.	Mar 2007	A1
20070088424	Greenberg et al.	Apr 2007	A1
20070112420	LaDuca	May 2007	A1
20070118208	Kerr	May 2007	A1
20070123805	Shireman et al.	May 2007	A1
20070142896	Anderson et al.	Jun 2007	A1
20070150051	Arnault De La Menardiere et al.	Jun 2007	A1
20070167955	Arnault De La Menardiere et al.	Jul 2007	A1
20070168019	Amplatz et al.	Jul 2007	A1
20070173921	Wholey et al.	Jul 2007	A1
20070179592	Schaeffer	Aug 2007	A1
20070198076	Hebert et al.	Aug 2007	A1
20070203571	Kaplan et al.	Aug 2007	A1
20070213804	Schaeffer et al.	Sep 2007	A1
20070219620	Eells et al.	Sep 2007	A1
20070219621	Hartley et al.	Sep 2007	A1
20070225796	Yadin et al.	Sep 2007	A1
20070225797	Krivoruhko	Sep 2007	A1
20070225798	Gregorich	Sep 2007	A1
20070233220	Greenan	Oct 2007	A1
20070244540	Pryor	Oct 2007	A1
20070244542	Greenan et al.	Oct 2007	A1
20070244547	Greenan	Oct 2007	A1
20070248640	Karabey et al.	Oct 2007	A1
20070250084	Sharkway et al.	Oct 2007	A1
20070260302	Igaki	Nov 2007	A1
20070260304	Gregorich et al.	Nov 2007	A1
20070149166	Schaeffer et al.	Dec 2007	A1
20070293940	Schaeffer et al.	Dec 2007	A1
20070299494	Zukowski	Dec 2007	A1
20070299495	Zukowski et al.	Dec 2007	A1
20070299497	Shaolian et al.	Dec 2007	A1
20070299499	Hartley	Dec 2007	A1
20070299501	Hebert et al.	Dec 2007	A1
20080009932	Ta et al.	Jan 2008	A1
20080009933	Ta et al.	Jan 2008	A1
20080009937	Kipperman	Jan 2008	A1
20080015681	Wilson	Jan 2008	A1
20080033525	Shaked et al.	Feb 2008	A1
20080046066	Jenson et al.	Feb 2008	A1
20080058918	Watson	Mar 2008	A1
20080065197	Meyer et al.	Mar 2008	A1
20080071343	Mayberry et al.	Mar 2008	A1
20080086191	Valencia	Apr 2008	A1
20080109065	Bowe	May 2008	A1
20080114444	Yu	May 2008	A1
20080114446	Hartley	May 2008	A1
20080133000	Molony	Jun 2008	A1
20080167704	Wright et al.	Jul 2008	A1
20080172119	Yamasaki et al.	Jul 2008	A1
20080172122	Mayberry et al.	Jul 2008	A1
20080188921	Yamasaki et al.	Aug 2008	A1
20080208310	McDermott	Aug 2008	A1
20080208319	Rabkin et al.	Aug 2008	A1
20080255652	Thomas et al.	Oct 2008	A1
20080262595	Chu et al.	Oct 2008	A1
20080262596	Xiao	Oct 2008	A1
20080269866	Hamer et al.	Oct 2008	A1
20080269867	Johnson	Oct 2008	A1
20080275542	LaDuca	Nov 2008	A1
20080281399	Hartley	Nov 2008	A1
20080294237	Chu	Nov 2008	A1
20090005847	Adams	Jan 2009	A1
20090012602	Quadri	Jan 2009	A1
20090043373	Arnault de la Menardiere et al.	Feb 2009	A1
20090043377	Greenberg et al.	Feb 2009	A1
20090048663	Greenberg	Feb 2009	A1
20090069880	Vonderwalde et al.	Mar 2009	A1
20090088791	Drasler et al.	Apr 2009	A1
20090099649	Chobotov et al.	Apr 2009	A1
20090109065	Pinheiro	Apr 2009	A1
20090132024	Berkhoff	May 2009	A1
20090155337	Schreck et al.	Jun 2009	A1
20090164001	Biggs et al.	Jun 2009	A1
20090240316	Bruszewski	Sep 2009	A1
20090254170	Hartley et al.	Oct 2009	A1
20090259290	Bruszewski et al.	Oct 2009	A1
20090259296	McIff et al.	Oct 2009	A1
20090264985	Bruszewski	Oct 2009	A1
20090287145	Cragg et al.	Nov 2009	A1
20100063575	Shalev et al.	Mar 2010	A1
20100063576	Schaeffer et al.	Mar 2010	A1
20100094390	Goldmann et al.	Apr 2010	A1
20100179636	Mayberry et al.	Jul 2010	A1
20100179638	Shaolian et al.	Jul 2010	A1
20100261662	Schreck et al.	Oct 2010	A1
20110054586	Mayberry et al.	Mar 2011	A1
20110054587	Mayberry et al.	Mar 2011	A1
20110288627	Hartley et al.	Nov 2011	A1
20120109279	Mayberry	May 2012	A1
20140249615	Schreck	Sep 2014	A1
20140350658	Benary et al.	Nov 2014	A1
20150173932	Mayberry	Jun 2015	A1
20150366688	Schreck	Dec 2015	A1

Foreign Referenced Citations (91)

Number	Date	Country
2220141	Nov 1996	CA
2133530	Jan 1999	CA
295 21 548	Feb 1995	DE
295 21 776	Feb 1995	DE
100 17 147	Oct 2001	DE
0 282 175	Sep 1988	EP
0 323 176	Jul 1989	EP
O 177 330	Jun 1991	EP
0 458 568	Nov 1991	EP
0 596 145	May 1994	EP
0 621 015	Oct 1994	EP
0 659 389	Jun 1995	EP
0 688 545	Dec 1995	EP
0 689 806	Jan 1996	EP
0 712 614	May 1996	EP
0 732 088	Sep 1996	EP
0 732 089	Sep 1996	EP
0 732 089	Sep 1996	EP
0 740 928	Nov 1996	EP
0 740 928	Nov 1996	EP
0 747 020	Dec 1996	EP
0 732 089	Feb 1997	EP
0 775 470	May 1997	EP
0 782 841	Jul 1997	EP
0 783 873	Jul 1997	EP
0 783 874	Jul 1997	EP
0 880 938	Dec 1998	EP
0 880 948	Dec 1998	EP
0 904 745	Mar 1999	EP
0 974 314	Jan 2000	EP
0 732 088	Apr 2000	EP
1 433 438	Jun 2004	EP
1 470 797	Oct 2004	EP
0 935 374	Jan 2005	EP
1 935 374	Jun 2008	EP
2 429 452	Mar 2012	EP
2 635 241	Sep 2013	EP
1 038 606	Jul 1998	ES
04-25755	Jan 1992	JP
08-336597	Dec 1996	JP
9-511160	Nov 1997	JP
2000-500047	Jan 2000	JP
2007-236472	Sep 2007	JP
5629871	Oct 2014	JP
WO 9313825	Jul 1993	WO
WO 9424961	Nov 1994	WO
WO 9521592	Aug 1995	WO
WO 9634580	Nov 1996	WO
WO 9639999	Dec 1996	WO
WO 96041589	Dec 1996	WO
WO 9710757	Mar 1997	WO
WO 9710777	Mar 1997	WO
WO 97014375	Apr 1997	WO
WO 97019652	Jun 1997	WO
WO 97026936	Jul 1997	WO
WO 97033532	Sep 1997	WO
WO 97045072	Dec 1997	WO
WO 98002100	Jan 1998	WO
WO 98011846	Mar 1998	WO
WO 98027895	Jul 1998	WO
WO 980027894	Jul 1998	WO
WO 98053761	Dec 1998	WO
WO 99013808	Mar 1999	WO
WO 99029262	Jun 1999	WO
WO 99044536	Sep 1999	WO
WO 99047077	Sep 1999	WO
WO 99053865	Oct 1999	WO
WO 99058084	Nov 1999	WO
WO 00033769	Jun 2000	WO
WO 00053251	Sep 2000	WO
WO 01003762	Jan 2001	WO
WO 01026707	Apr 2001	WO
WO 01067993	Sep 2001	WO
WO 0239888	May 2002	WO
WO 03094796	Nov 2003	WO
WO 04047885	Jun 2004	WO
WO 04089249	Oct 2004	WO
WO 04105693	Dec 2004	WO
WO 05037076	Apr 2005	WO
WO 05037141	Apr 2005	WO
WO 06028925	Mar 2006	WO
WO 06036690	Apr 2006	WO
WO 06047708	May 2006	WO
WO 07027830	Mar 2007	WO
WO 08034106	Mar 2008	WO
WO 08083767	Jul 2008	WO
WO 08086084	Jul 2008	WO
WO 09000546	Dec 2008	WO
WO 09105699	Aug 2009	WO
WO 10127040	Nov 2010	WO
WO 12061526	May 2012	WO

Non-Patent Literature Citations (15)

Entry
US 6,413,270 B1, 07/2002, Thornton et al. (withdrawn)
Definition of “mounted”, Dictionary.com, retrieved Nov. 18, 2010 from http://dictionary.com/browse/mounted.
International Preliminary Report on Patentability and Written Opinion re PCT/US2011/059012, dated May 7, 2013.
International Search Report and Written Opinion re PCT/US2011/059012, dated Jul. 12, 2012.
Minion et al., “Technique of slow deployment of Gore Excluder endograft improves accuracy of placement”, J Vasc Surg 43:852-4, 2006.
European Office Action dated Oct. 28, 2015, from application No. 11781956.5.
Final Office Action dated Dec. 3, 2015, from U.S. Appl. No. 13/287,907.
Final Office Action dated Nov. 2, 2016, from U.S. Appl. No. 13/287,907.
Japanese Office Action dated Jul. 10, 2017, from application No. 2013-537796.
Japanese Office Action dated Mar. 30, 2017, from application No. 2013-537796.
Japanese Office Action dated May 20, 2016, from application No. 2013-537796.
Japanese Office Action dated Sep. 7, 2015, from application No. 2013-537796.
Non-final Office Action dated Apr. 20, 2016, from U.S. Appl. No. 13/287,907.
Non-final Office Action dated May 21, 2015, from U.S. Appl. No. 13/287,907.
Non-final Office Action dated Oct. 22, 2014, from U.S. Appl. No. 13/287,907.

Related Publications (1)

	Number	Date	Country
	20170128246 A1	May 2017	US

Provisional Applications (1)

	Number	Date	Country
	61409504	Nov 2010	US

Divisions (1)

	Number	Date	Country
Parent	13287907	Nov 2011	US
Child	15414499		US

Apparatus and method of placement of a graft or graft system

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Term Extension

Abstract